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Abstract 
The amygdala and the cholinergic system play important roles in learning and 
memory. The amygdala receives substantial cholinergic innervation and in itself ex-
presses differences in this innervation. p75NTR is one of the primary receptors of cho-
linergic neurons and transgenic mice that are missing exon IV of the p75 neurotro-
phin receptor locus, display a change in cholinergic innervation. The loss of p75NTR 
can induce changes in learning and memory so it was hypothesized p75EXIV animals 
would display an enhancement in cholinergic induced plasticity in the amygdala, due 
to increased cholinergic innervation in these mice, and a difference between the BL 
and La nuclei would be seen. As expected, ChAT immunohistochemistry showed a 
stark difference in cholinergic innervation between the BL and La nuclei of the amyg-
dala. Field potential recordings, as well as PPF and LTP, did not show any differences 
between BL and La in wt animals therefore sharp microelectrode recording and a 
standard plateau firing paradigm were used to determine intrinsic differences in pro-
jection neurons for the BL and La nuclei. Sharp recordings revealed a difference in 
plateau firing induction for BL neurons as well as a hyperpolarizing membrane deflec-
tion. As in wt animals, there were no differences seen between the BL and La for 
field recordings in ko mice; although, paired pulse facilitation and LTP elucidated a 
reduction in transmitter release as well as disrupted postsynaptic maintenance in 
p75EXIV animals as compared to wt. Field potential recordings with cholinergic chal-
lenge also indicated a difference in cholinergic signaling in p75EXIV animals. In contrast 
with the original hypothesis, p75EXIV animals did not display an enhancement of cho-
linergic induced plasticity in the amygdala but rather impairment. 
Zusammenfassung 
Die Amygdala und das cholinerge System spielen eine wichtige Rolle bei Lern- und 
Gedächtnisprozessen. Die Amygdala wird sehr reichhaltig von cholinergen Fasern 
innerviert und zeigt dabei in sich selbst ausgeprägte Unterschiede bezüglich dieser 
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Innervation. P75NTR ist einer der primären Rezeptoren cholinerger Neurone und 
transgene Mäuse, welchen der Gen-Lokus Exon IV des p75-Neurotrophinrezeptors 
fehlt, haben eine phänotypisch deutlich veränderte cholinerge Innervation. Der 
Verlust des P75-Neurotrophinrezeptors kann Veränderungen bezüglich von Lern- und 
Gedächtnisprozessen induzieren. Bei entsprechenden transgenen P75ExIV-Mäusen 
wurde eine durch das cholinerge System induzierte erhöhte Plastizität in der 
Amygdala aufgrund der hier generell reichhaltigeren cholinergen Innervation und 
diesbezüglich auch Unterschiede zwischen BL- und La-Nukleus postuliert. ChAT-
immunohistochemische Untersuchungen zeigten dabei erwartungsgemäß, dass sich 
die entsprechende Innervation bei beiden Kernen erheblich unterscheidet. Durch 
extrazelluläre Feldpotentialableitungen (fEPSPs), sowohl PPF-Messungen und auch 
Registrierung der LTP, konnten bei Wildtyp-Mäusen keine Unterschiede zwischen BL- 
und La-Kern gezeigt werden. Daher wurden intrazelluläre Ableitungen mit der 
Glasmikroelektrode und standartisierte plateau-firing Paradigmen angewandt, um 
etwaige Unterschiede bezüglich der intrinsischen Eigenschaften der jeweiligen 
Projektionsneurone beider Kerne zu untersuchen. So konnte gezeigt werden, das die 
Induktion des plateau firing bei BL-Neuronen und La-Neuronen verschieden ist und 
dass BL-Neuronen eine Hyperpolarisationsablenkung des Membranpotentials zeigen. 
Bei Knockoutmäusen konnten durch fEPSP-Messungen ebenso keinerlei 
Unterschiede zwischen BL- und La-Kern festgestellt werden, wenn auch PPF- und 
LTP-Messungen bei transgenen Tieren im Vergleich zu Wildtypmäusen eine etwas 
verringerte Transmitterausschüttung sowie einen veränderten Zeitverlauf der LTP 
aufzeigten. Wurden fEPSPs unter cholinerger Anregung gemessen, war bei den 
transgenen P75ExIV-Tieren das cholinerge Signaling verändert. Im Gegensatz zur 
ursprünglichen Hypothese war die durch das cholinerge System induzierte Plastizität 
in der Amygdala bei P75ExIV-Mäusen nicht erhöht, sondern sogar reduziert. 
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Abbreviations 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
µl micro liter 
µs micro second  
2-APB  Diphenylboric acid 2-aminoethyl ester 
AcCoA acetyl-Coenzyme A 
ACh acetylcholine 
AChE acetylcholinesterase 
AChRs acetylcholine receptor(s) 
aCSF artificial cerebral spinal fluid 
AD Alzheimer’s Dieseas 
AHP after hyperpolerization 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid 
AP action potential 
BDNF brain derived neurotrophic factor 
BFCNs basal forebrain cholinergic neurons 
BL basolateral nucleus 
BLA basolateral amygdala 
BM basomedial nucleus 
BV basoventral 
CaMKII calcium/calmodulin-dependent protein kinase II 
CAN  calcium activated nonspecific cation current 
Ce central nucleus 
CED cambridge electronic design 
ChAT choline acetyltransferase 
CHT sodium dependant choline transporter 
Abbreviations 
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CNS central nervous system 
CS conditioned stimulus 
DAG diacyglycerol 
DAPI 2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride 
DG Dentate Gyrus 
DNA dxeoxyribonucleic acid 
EC external capsule 
EEG electroencephalogram 
E-LTP early phase long term potentiation 
fEPSPs field excitatroy synaptic potential(s) 
fp field potential 
FST fine science tools 
GDP guanosine diphospate 
GEF guanine nucleotide exchange factor 
GPCRs G protein coupled receptors 
GTP  guanosine triphospate 
HDB horizontal limb of the diagonal band of Broca 
HFS high frequecncy stimulation 
HS horse serum 
Hz Hertz 
IAHP afterhyperpolerization current 
IP3 inositol 1,4,5-triphosphate 
ISI interstimulus interval 
KCa calcium activated potassium current 
ko knock out animal 
La lateral nucleus 
LGIC ligand gated ion channel 
LTD  long term depression 
L-LTP late phase long term potentiation 
Abbreviations 
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LTP long term potentiation 
mAChRs muscarinic acetylcholine receptor(s) 
Me medial nucleus 
mGluR metabotropic glutamate receptors 
ml mililiter 
ms milisecond 
MS medial septum 
MΩ mega ohm 
nA nano ampre 
nAChRs nicotinic acetylcholine receptor(s) 
NB nucleus basalis 
NbM nucleus basalis of meynert 
NGF nerve growth factor 
NMDAR N-Methyl-D-Aspartate Receptor 
NT-4  neurotrophin 
NTRs neurotrophin receptor(s) 
PB phosphate buffer 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PFA paraformaldehyde 
PFC prefrontal cortex 
PIP2 phosphatidylinositol 4,5-bisphosphate 
PKC protein kinase C 
PLC phospholipase C 
PNS peripheral nervous system 
PPF paired pulse facilitation 
PTP post tetanic potentiation 
PTSD post traumatic stress disorder 
REM rapid eye movement 
Abbreviations 
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RT room temperature 
s second 
sem standard error of the mean 
SI substantia innominata 
SK small conductance calcium-activated K potassium channels 
TBE tris-borate-EDTA 
TNFR necrosis factor receptor 
TrkA tropomyosin receptor kinase A 
UR unconditioned response 
US unconditioned stimulus 
VAChT vesicular ACh transporter 
VDB vertical band of Broca 
VGCCs voltage gated calcium channel 
VM membrane potential 
wt wild type animal 
 
 
 
 
 
Literature Review 
Cline 2010 1 
1 Introduction 
Classically seen as the region responsible for emotions and emotion based learning, 
the amygdala is now being implicated in other forms of learning as well as cognitive 
performance. It displays a key feature in the consolidation of memory as greater 
amygdala activation determines which sensory inputs will be stored long term rather 
than transiently. Experiences that are able to provoke a strong amygdala response 
generally give rise to late phase long term potentiation (L-LTP) resulting in lasting and 
sustainable plasticity and therefore memory retention; whereas weakly evoked 
amygdala responses usually result in the deterioration over time of resulting memo-
ries or their complete lack of retention [1]. 
As part of the overall limbic system, the amygdala shares connections with the hip-
pocampus, the entorhinal cortex, dentate gyrus as well as other cortices [2]. It re-
ceives substantial innervations from the Nucleus Basalis of Meynert (N. Meynert) 
linking it with basal forebrain cholinergic neurons (BFCNs). The primary cholinergic 
ligand is Acetylcholine, which binds to either nicotinic acetylcholine receptors (nA-
ChRs) or muscarinic acetylcholine receptors (mAChRs) [3]. Survival of BFCNs is highly 
dependent upon the neurotrophin Nerve Growth Factor (NGF) and its high affinity 
receptor tropomyosin receptor kinase A (TrkA). NGF has also been shown to facilitate 
neurotransmission between the N. Meynert and that of the amygdala [4].  
Degeneration of Basal Forebrain Cholinergic Neurons has been shown to be one of 
the principal contributing factors to Alzheimer’s disease (AD). The loss of BFCNs gives 
rise to lower innervation of cortical regions resulting in memory lost, the inability to 
retain new information, as well as attention deficits [5]. One of the primary causes 
for this loss of neurons is the lack of binding of NGF to TrkA receptors. Mice that are 
lacking TrkA receptors show a substantial decrease in amygdala cholinergic innerva-
tion as well as decimation in the size of cholinergic neurons [6], whereas mice that 
Literature Review 
Cline 2010 2 
are lacking the low affinity neurotrophin receptor p75NTR have an increase in the 
amount of afferent amygdala cholinergic fibers as well as larger neuronal size [7]. 
As already stated, the amygdala is now being seen as playing a pivotal role in 
memory consolidation. The ability of the amygdala to modulate other members of 
the limbic system has been demonstrated in great detail of late. Electrical stimulation 
of the amygdala can reinforce LTP in the Dentate Gyrus (DG) as well as transform 
early phase LTP (E-LTP) into L-LTP [8]. The ability of the amygdala to produce persis-
tent firing due to cholinergic modulation has also been demonstrated [9]. It is 
thought that persistent firing gives a single neuron the ability to retain transient in-
formation until such information can be consolidate. 
The cholinergic system is integral to the central and peripheral nervous systems and 
to the neuromuscular junction of skeletal and smooth muscles. Due to its wide dis-
tribution, the cholinergic system has an extremely broad physiological relevance 
both in normal and pathological states [10]. In the brain, the cholinergic system plays 
a central role in analgesia, cognition, memory and neuroprotection, whereas in the 
skeletal muscle the system is responsible for contraction. Impairment in cholinergic 
transmission results in selective loss of cholinergic neurons with subsequent neuro-
pathological conditions. 
2 Literature Review 
2.1 Cholinergic System 
The broad scope of the cholinergic system is far too vast for the purposes of this dis-
sertation. It is involved in regulating the CNS [11], PNS [12], as well as other areas 
where the cholinergic system is considerably overlooked; and plays a role in matters 
such as cell proliferation and differentiation [13]. Highly specialized systems, such as 
that of the immune system, have their own integrated cholinergic system [10, 14]. 
Therefore, the brief literature review here will focus on the cholinergic system of the 
basal forebrain.   
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2.1.1 Discovery of Acetylcholine 
The existence of neurotransmitters is a process that took 35 years and much contro-
versy to fully establish. It was tempestuously contested whether transmission across 
synapses was electrical or chemical and the early trailblazers were forced to work 
with the peripheral nervous system (PNS) prolonging the debate for another 30 years 
in the central nervous system (CNS) [15].  
Henry Hallett Dale is contributed as being the first to discover acetylcholine. While 
working with the fungus ergot, Dale extracted multiple compounds which mimicked 
either sympathetic or parasympathetic nerve stimulation including an amine, with 
similar properties to adrenaline, histamine, and ergotoxine, with properties similar to 
acetylcholine, and finally acetylcholine [16, 17]. Acetylcholine is not a normally oc-
curring substance in ergot but as chance favors the prepared, the ergot happened to 
be infected with the bacterium Bacillus acetylcholini and since cholinesterase is also 
not naturally present in ergot, there was an abundance of stable acetylcholine [15]. 
Dale also made a substantial contribution to the understanding of synaptic transmis-
sion as he observed that acetylcholine and muscarine exhibited the same effects at 
some sites but not others. However, low doses of nicotine displayed the same effect 
as acetylcholine at sites where muscarine did not. Thus Dale foreshadowed that the 
effects must be due to “receptor substances” and he labeled the differences as mus-
carinic and nicotinic [18]. Dale also observed that the effect of acetylcholine was “in-
tense”, “immediate” and “extraordinarily evanescent” and thus concluded that an 
esterase must also exists which rapidly breaks down acetylcholine into acetic acid 
and an inactive choline [19].  
Otto Loewi has been distinguished as the first to demonstrate that synaptic transmis-
sion was indeed chemical although it was not conclusively accepted for a conspicu-
ously length of time. It is best to describe the work of Loewi through his own words:  
The night before Easter Sunday of that year I awoke, turned on the light, and jotted down a few 
notes on a tiny slip of thin paper. Then I fell asleep again. It occurred to me at six o’clock in the 
Literature Review 
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morning that during the night I had written down something most important, but I was unable to 
decipher the scrawl. The next night, at three o’clock, the idea returned. It was the design of an ex-
periment to determine whether or not the hypothesis of chemical transmission that I had uttered 
seventeen years ago was correct. I got up immediately, went to the laboratory, and performed a 
simple experiment on a frog heart according to the nocturnal design.  
The hearts of two frogs were isolated, the ﬁrst with its nerves, the second without. Both hearts were 
attached to Straub cannulas ﬁlled with a little Ringer solution. The vagus nerve of the ﬁrst heart was 
stimulated for a few minutes. Then the Ringer solution that had been in the ﬁrst heart during the 
stimulation of the vagus was transferred to the second heart. It slowed and its beats diminished just 
as if its vagus had been stimulated. Similarly, when the accelerator nerve was stimulated and the 
Ringer from this period transferred, the second heart speeded up and its beats increased. [20] 
Loewi named the first substance secreted via stimulation of the vagus nerve Va-
gusstoff and the other Acceleransstoff. His initial publication “Über humorale Über-
tragbarkeit der Herznervenwirkung” [21] started what would be a fire storm debate 
as to whether or not synapses did indeed release chemicals for the next 30 years. For 
their revolutionary work, both Dale and Loewi were awarded The Nobel Prize in 
Physiology or Medicine in 1936. A better appreciation of the two men can be ob-
tained from reading Feldberg 1970 [22] and Dale 1962 [23]. 
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2.1.2 Acetylcholine Synthesis, Release, and Metabolism 
Acetylcholine (ACh) synthesis is facili-
tated by the enzyme choline acetyl-
transferase (ChAT) in nerve terminals. 
The enzyme catalyzes the acetylation 
of choline by acetyl-Coenzyme A (Ac-
CoA) which is derived from glucose 
[24]. Following synthesis, ACh is then 
transferred into synaptic vesicles via a 
vesicular ACh transporter (VAChT) 
where it is stored until release [25].  
Release occurs when cholinergic neurons are sufficiently depolarized creating an ac-
tion potential (AP) allowing synaptic vesicles to bind to the presynaptic terminal and 
releasing ACh into the synaptic cleft via exocytosis. Upon release, ACh is quickly hy-
drolyzed by the enzyme acetylcholinesterase (AChE) into choline and acetate. AChE is 
extremely efficient as one molecule of AChE has the ability to hydrolyze 5000 mole-
cules of ACh per second [26, 27]. Choline is then returned to the presynaptic terminal 
via a high affinity, sodium dependent choline transporter (CHT) located at the plasma 
membrane of cholinergic neurons [28, 29].  Since ChAT and VAChT are both neces-
sary for the creation and storage of ACh, markers for ChAT and VAChT are acceptable 
means for elucidating cholinergic neurons [30, 31].  
2.1.3 Acetylcholine Transmission 
The mode of transmission of acetylcholine is under great scrutiny at the moment due 
to its brazen contradictory effects. It is suggested that there exist underlying basal 
levels of ACh that incur fluctuations and thus accounts for the actions of ACh; imply-
ing a form of volume transmission. Volume transmission being that, neurotransmit-
ter release moves into the extra synaptic space and produces effects by binding to 
receptors outside the synapse [32]. On the other side of the coin, is the more classi-
cal form of neurotransmitter release known as wired transmission. This being the 
Figure 2.1.1 | ACh Synthesis and Hydrolysis ACh is acety-
lated with choline by AcCoA. It is hydrolyzed into acetate 
and choline via AChE 
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case that ACh is released into the synaptic cleft and its actions are solely contrived in 
the synapse; bringing forth yet two more arguments of phasic or tonic action [33].  
 Figure 2.1.2 | The main characteristics of wired and volume transmission In the wired model of cholinergic 
neurotransmission (a), the presence and high catalytic activity of AChE restricts the neurotransmission to clas-
sic synapses or junctional complexes. By contrast, in the volume model of cholinergic neurotransmission (b), 
most presynaptic cholinergic terminals in the cortex do not form junctional complexes and so neurotransmis-
sion is mediated by ACh that escapes hydrolysis because of insufficient or regulated availability and/or activity 
of AChE. This ACh reaches the extracellular space and can stimulate non-junctional nAChRs and mAChRs. 
Adapted from Sater et al 2009 [34] 
2.1.4 Cholinergic Receptors 
Cholinergic receptors, also known as acetylcholine receptors (AChRs) are classified 
either as muscarinic acetylcholine receptors (mAChRs) or as nicotinic acetylcholine 
receptors (nAChRs). Both receptor types respond to their endogenous ligand ACh, 
however, as their name implies, only muscarinic receptors respond to muscarine 
while nicotinic receptors respond to nicotine. 
2.1.5 Muscarinic Cholinergic Receptors 
Muscarine was first discovered when the psychopharmacological actions of the 
mushroom Amanita muscaria were being investigated in 1869 [35]. There are be-
lieved to be possibly 9 different subdivisions of muscarinic receptors [36] the current 
consensus is that there exist 4 pharmacologically identified subdivisions designated 
with upper case letters as M1-M4 and 5 immunologically/genetically identified re-
ceptor subclasses identified with lower case letters as m1-m5 [37, 38].   Muscarinic 
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receptors consist of single unit proteins folded into  7 transmembrane domains and a 
large cytoplasmic domain between regions 5 and 6 [39]. mAChRs belong to the super 
class of G protein coupled receptors (GPCRs) and thus induce signal transduction via 
catalyzing the exchange of guanosine diphospate (GDP) for guanosine triphosphate 
(GTP) when activated, acting as a guanine nucleotide exchange factor (GEF) [40, 41]. 
As with all GPCRs, muscarinic receptors can further be classified by the type of the G 
protein they are associated with; primarily due to the alpha subunit which deter-
mines which downstream effectors are activated upon the disassociation of the G 
protein complex. When mAChRs are activated, the G protein disassociates into α and 
βγ subunits, which in turn, activate corresponding downstream effectors [42, 43]. 
Classically, most attention has been giving to the alpha subunit which is further di-
vided into four subtypes determining its activation capacity. However, the capacity of 
the beta-gamma complex to primarily activate ion channels is becoming ever more 
lucid [43]. Table one illustrates the mAChRs subtypes along with their associated G 
proteins, including their known second messenger cascades.  
Table 2.1.1 | mAChRs: signal transduction 
 mAChR subtype    
 M1 M2 M3 M4 M5 
Preferred sig-
nal transduc-
tion 
Gq/11 
PLC/IP3/DAG/CA
2+ 
PKC 
Gi/o 
AC 
(inhibition) 
Gq/11 
PLC/IP3/DAG/CA
2+ 
PKC 
Gi/o 
AC 
(inhibition) 
Gq/11 
PLC/IP3/DAG/CA
2+ 
PKC 
      
PLC, phospholipase-C; IP3, inositol 1,4,5-triphosphate; DAG, diacyglycerol; PKC, protein kinase C; AC, adenylate 
cyclase Adapted from Langmead et al 2008 [44] 
2.1.6 Nicotinic Cholinergic Receptors 
Tobacco and indirectly nicotine has been used for thousands of years. The genus Ni-
cotiana received its name from the French ambassador Jean Nicot who introduced 
tobacco to France and indirectly the whole of Europe. Wilhelm Heinrich Posselt and 
Karl Ludwig Reimann coined the term alkaloid and gave nicotine its name in their 
thesis submission to the University of Heidelberg in 1828 as they were the first to 
successfully isolate nicotine in its pure form [45]. Ironically, the pioneering research 
in nicotine was conducted by the R. J. Reynolds Tobacco Co. which is now the second 
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largest tobacco company in the U.S.A and continues to lead research in the fields of 
nicotine addiction and Alzheimer’s Disease therapeutics [46]. 
Unlike mAChRs, nAChRs are ligand gated ion channel receptors (LGIC) that consist of 
five subunits (α,β, γ, δ,ε) surrounding a cation permeable core. Each subunit has four 
transmembrane segments, a long N-terminal domain, an intracellular loop between 
transmembrane segments 3 and 4, and finally a short C-terminal domain [47]. Neu-
ronal nicotinic receptors are composed of heteromer combinations of α (2-6) and β 
(2-4) subunits as well as homomers of α7 and α9 and finally heteromers of α9 and 
α10 subunits [48]. The combination of nAChRs subunits determines the channel ki-
netics for the given receptor as well as its physiopharmacological properties. Current-
ly the best understood neuronal receptor types are the α4β2 heteromer and the α7 
homomer , however, the diverse possible subunit combinations gives rise to a near 
infinite possibility of nAChR receptor types [49]. Nicotinic receptors exist primarily in 
three principal states: activated, inactivated, and desensitized. In the desensitized 
state, the channel is inactivated and incapable of ligand binding. Upon ligand binding 
(usually 2 ligands), the channel becomes activated and permeable to K+, Na+, and 
Ca2+ ions. The ratio between which ions are permeable or favored is directly related 
to the subunits constituting the nAChR. Presynaptically located, nAChRs can directly 
induce neurotransmitter release via the influx of Ca+2 or indirectly through activating 
voltage gated calcium channels (VGCCs). Postsynaptically, nAChRs can activate intra-
cellular signaling cascades and gene transcription [50].   
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2.2 Cholinergic Projections 
In 1967, Lewis and Shute made the first substantial contributions to the understand-
ing of cholinergic neurons and their projections [51-53]. Then sixteen years thereaf-
ter, Mesulam introduced a Ch classification system to distinguish cholinergic groups 
based upon their topographical location as well as their cortical and subcortical pro-
jections [54].  
2.2.1 Basal Forebrain 
Cholinergic neurons of the basal forebrain innervate the entire cerebral cortex and 
contain the cholinergic areas Ch1 to Ch4 based upon Mesulam nomenclature [54]. 
Ch1 neurons refer to cholinergic neurons of the medial septum (MS) which project 
primarily to the hippocampus but as well to the cingulated cortex, olfactory bulb and 
hypothalamus [55]. Cholinergic neurons of the vertical limb of the diagonal band of 
Broca (VDB) are classified as Ch2 and project also primarily to the hippocampus along 
with the fore mentioned projections of Ch1 [55]. Ch3 neurons comprise those of the 
horizontal limb of the diagonal band (HDB) and constitute the major cholinergic 
pathway of the olfactory bulb [56]. The final cholinergic constituent of the basal 
forebrain is area Ch4 which refers to the densest set of cholinergic neurons located 
in the nucleus basalis of Meynert (NbM) also commonly referenced as nucleus basal-
is (NB) or substantia innominata (SI). The NB projects primarily to the amygdala as 
well as to the rest of the cerebral cortex that does not receiving other cholinergic 
projections [57]. 
2.2.2 Brain Stem 
The brainstem cholinergic system consists of four cholinergic cell groups Ch5 to Ch8. 
Ch5 designates cholinergic cells in the pedunculopontine nucleus, and Ch6 cells in 
the laterodorsal tegmental nucleus and rostral brainstem. The Ch5 and Ch6 cells pro-
ject to the thalamus. Ch7 cells in the medial habenula innervate the interpeduncular 
nucleus, and Ch8 cells in the parabigeminal nucleus project to the superior colliculus 
[54, 58].     
Literature Review 
Cline 2010 10 
2.2.3 Identification of Cholinergic Neurons  
For the identification of cholinergic neurons, there are numerous methods and 
markers available. The most widely used methods consist of immunohistochemistry, 
immunocytochemistry, in situ hybridization, as well as polymerase chain reaction 
(PCR) and its derivatives [59].  Commonly used markers for cholinergic neurons in-
clude choline acetyltransferase, vascular acetylcholine transporter, acetylcholines-
terase, and finally the choline high affinity transporter [60-62]. It is generally accept-
ed that identification with either ChAT or VChAT is conclusive enough for cholinergic 
neurons. AChE, as a cholinergic marker, is considered to be unspecific and therefore 
normally only used in conjunction with another marker. CHT, although considered a 
highly specific conclusive cholinergic marker, is limited to nerve terminals and there-
fore not as widely used [63]. 
2.2.4 Characteristics of Cholinergic Neurons 
The prime characteristic of basal forebrain cholinergic neurons (BFCNs) is their ex-
pression of the tropomyosin receptor kinase A (TrkA) and the binding of the endoge-
nous ligand nerve growth factor (NGF) gives the BFCNs their respected phenotype 
[64]. Most BFCNs also express all neurotrophin receptors in varying ratios but it is the 
loss of TrkA expression which leads to the onset of mild cognitive impairment and 
later Alzheimer’s disease [65]. While a vast majority of BFCNs also express the low 
affinity p75NTR receptor, more than 90 percent in the MS and diagonal band of Borca 
[66], there exist a subpopulation of cholinergic neurons in the nucleus basalis which 
do not. Cholinergic lesions with 192 IgG-saporin directed against p75NTR abolishes 
BFCNs in all areas except for that of the NB and cholinergic neurons in this area show 
high ChAT reactivity but very low p75NTR expression following 192 IgG-saporin [67, 
68]. 
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2.3 Acetylcholine Neuromodulation  
The cholinergic system plays a pivotal role in modulating learning and memory, 
arousal, sleep, and cognition [69]. It achieves these effects through the modification 
of intrinsic functions on the neuronal level as well as setting the oscillatory tone on 
the network level [33].     
2.3.1 Intrinsic Modulation 
Intrinsically, ACh modifies action potential adaptation as well as membrane potential 
and resistance. It is believed that one of the primary purposes of ACh modulation is 
to limit intrinsic neuronal excitability and thus increase the fidelity of extrinsic excita-
tion [70]. The increased intrinsic inhibition also functions as a  neuroprotective 
mechanism against over excitation [71]. Intrinsic inhibition and  excitation from af-
ferent projections  facilitates network contiguity during ACh release [33]. Both nA-
ChRs and mAChRs have the ability to activate slow conductance calcium activated 
potassium channels (SK) [70, 72]. SK channels are heteromeric complexes of SK-α 
subunits and calmodulin and are gated by changes in intracellular Ca2+ in a voltage-
independent manner [73, 74]. These channels are activated by Ca2+ binding to cal-
modulin that induces conformational changes resulting in channel opening [75]. SK 
channel activation results in K+ ions entering the cell and driving cell hyperpolariza-
tion forming the medium part of which is commonly referred to as the after hyperpo-
larization current (IAHP) [76]. The after hyperpolarization current is typically initiated 
by the firing of action potentials and its primary action is to limit AP firing causing ad-
aptation and decreasing firing frequency [77]. Paradoxically, the IAHP is both en-
hanced and abolished by ACh activation of mAChRs in pyramidal neurons located in 
the basolateral nucleus of the amygdala [70].      
2.3.2 Network Modulation 
Acetylcholine plays an essential role in the network integration of neurons of various 
cortical regions allowing for the processing of information via oscillatory synchroniza-
tion occurring primarily in the beta and gamma ranges (12 to 80 Hz) [78]. Cholinergic 
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Figure 2.3.1 | ACh on cortical dynamics High ACh 
levels enhances afferent input through action of nA-
ChRs and suppresses feedback excitation via presyn-
aptic inhibition of glutamate release through mAChRs. 
Low ACh levels results in weaker afferent input and a 
strengthening of excitatory feedback. Adapted from 
Hasselmo 2006 [69] 
activity is closely associated with cortical arousal [79] and is also strongly linked with 
enhanced sensory processing in the cortex [80] including heightened top-down in-
teractions, from higher associative cortices to lower sensory cortices [81]. Activation 
of nAChRs facilitates afferent inputs to the cortex, whereas the activation of mAChRs 
is important for enhancing intra laminar connections [82]. Muscarinic receptor acti-
vation is associated with gamma frequency oscillations and arousal [83]. In contrast, 
enhanced cortical activation by nicotine is associated with increased visual attention 
and working memory [84] including an increase in beta rhythm generation [85]. Ace-
tylcholine induces hippocampal oscillations in the 40 Hz range via the activation of 
mAChRs; the oscillation is dependent upon rhythmic inhibition through γ-
aminobutyric acid A receptors (GABAA) [86]. As in the hippocampus, nAChR induced 
beta rhythms in the auditory cortex are also dependent upon the activation of 
GABAARs [78].  
2.3.3 Learning and Memory      
Acetylcholine agonists enhance memory 
and learning performance when applied 
to brain regions associated with such 
learning and memory task at hand, 
whereas ACh antagonists disrupt per-
formance [87, 88]. The underlying cellu-
lar mechanisms for the effect of ACh on 
learning and memory include the en-
hancement of afferent input relative to 
excitatory feedback, regulation of inhibi-
tion and oscillations, increased persis-
tent spiking for active maintenance, and 
augmentation of synaptic modification (LTP) [69]. High levels of acetylcholine en-
hances the fidelity of sensory inputs via the activation of nAChRs allowing infor-
mation encoding while inhibiting the retrieval of already stored information by  de-
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creasing excitatory feedback through presynaptic inhibition elicited by the activation 
of mAChRs. Low levels of ACh reduce information from afferent sensory inputs and 
increases excitatory feedback by the removal of presynaptic inhibition and causing 
greater spiking activity and allowing the consolidation of newly learned information 
[33, 89].  
2.4 Field Recordings 
2.4.1 Long-term Potentiation 
LTP is the prolonged strengthening of synapses between neurons following brief but 
intense activation. It is believed to be one of the primary processes underlying the 
neuronal correlation to learning and memory.    
2.4.2 Hebbian Synapse 
In 1949, Donald Hebb revolutionized the way neuronal plasticity was viewed. Hebb 
predicted that plasticity was driven by the temporal juxtaposition of pre- and 
postsynaptic activity. Arguably Hebb’s most quoted statement, "When an axon of cell A is 
near enough to excite B and repeatedly or persistently takes part in firing it, some growth process or 
metabolic change takes place in one or both cells such that A's efficiency, as one of the cells firing B, 
is increased" [90] led to what is commonly referred to has Hebb’s Rule and is popularly 
summarized as “Neurons that fire together wire together”.  Hebb also argued that 
neurons functioned in cell assemblies and postulated that a specific function of the 
Hebbian synapse was the conversion of short term memory into that of long term 
[91].   
2.4.3 Finding LTP 
Hunting for synaptic analogues to learning, many techniques were deployed follow-
ing the postulations of Hebb. One of the building blocks was that of facilitation 
shown by Feng in 1941, which consists of the ability of an excitatory synapse to re-
lease more neurotransmitters following a single synaptic activation [92]. Following 
up on facilitation, in 1955 Cragg and Hamlyn demonstrated augmentation in the hip-
pocampus [93]. Augmentation occurs when a synapse is repeatedly activated and 
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there is an enhancement of synaptic response during and briefly following the re-
peated activations. Edging ever closer to a working demonstration of the Hebbian 
synapse, many groups reported on the ability of post tetanic potentiation (PTP) to 
induce fleeting synaptic augmentation following the initial activation. PTP is the abil-
ity of low frequency stimulation, generally below that of 50 Hz, or a short, high fre-
quency stimulation to briefly induce an enhancement of synaptic excitability. Yama-
moto and McIlwain came extremely close in 1966 when they elicited what was 
termed PTP, due to the short potentiation duration, using a 10 second 100 Hz stimu-
lation paradigm [94]. Finally, in 1973 Bliss and Loemo induced what they, at the time, 
called long lasting potentiation [95] which was later coined long-term potentiation in 
1975 by Douglas [96]. What was believed to be the long sought mechanism underly-
ing learning and synaptic plasticity was found and Hebb’s Rule became firmly 
grounded [97, 98].   
2.4.4 Induction of LTP 
Classical induction of LTP is in agreement with the Hebbian synapse in that presynap-
tic activity induces substantial postsynaptic activation resulting in the potentiation of 
the synapse. This form of LTP induction is N-Methyl-D-Aspartate Receptor (NMDAR) 
dependent. Presynaptic activity depolarizes the postsynaptic neuron through the ac-
tivation of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors (AMPA) 
[99-101]. Upon sufficient depolarization, the magnesium block of NMDARs is allevi-
ated in the postsynaptic neuron [102]. Upon removal of the voltage dependent Mg2+ 
ion blockade, NMDARs then become permeable to potassium, sodium and calcium 
ions [103]. The increased concentration of Ca2+ in the postsynaptic neuron through 
NMDA receptors is the principle initiator of LTP [104]. Ca2+ build up in the postsynap-
tic neuron triggers an increase in the amount of AMPA receptors present on the neu-
ron’s membrane, which thus further depolarizes the postsynaptic neuron activating 
more NMDARs and further increasing the levels of Ca2+ [105]. When Ca2+ concentra-
tions reach a sufficient level, then calcium/calmodulin-dependent protein kinase II 
(CaMKII) is activated [106, 107]. CaMKII autophosphorylation leads to the induction 
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of LTP by phosphorylating AMAPRs which increases their conductance to Na+ ions 
and thus synaptic potentiation [108].  
Most LTP studies have been conducted in the hippocampus and are the classical 
NMDAR dependent form of LTP [109]. However, other brain regions express other 
forms of LTP and the hippocampus also expresses non NMADAR dependent LTP. 
Generally LTP induction, which is not dependent upon the NMDA receptor, is termed 
non-Hebbian; as presynaptic activation is not a requisite for its induction. This non 
NMDAR dependent form of LTP requires the activation of G protein coupled recep-
tors and the release of internal Ca+2 stores via activation of the inositol 1,4,5-
triphosphate pathway [110, 111]. In hippocampus, non-Hebbian LTP is mediate by 
the activation of metabotropic glutamate receptors (mGluR) while in the amygdala, 
this form of LTP is dependent upon the activation of mAChRs [110, 112, 113]. Alt-
hough the receptor types are different in both brain areas, the primary mechanisms 
underlying LTP induction are virtually the same. Activation of GPCRs activates phos-
pholipase C (PLC) which induces IP3 and diacylglycerol (DAG) production from the hy-
drolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) [111, 114]. IP3 causes the re-
lease of intracellular Ca+2 from endoplasmic reticulum stores initiating LTP induction 
by triggering the buildup of AMPARs on the cell membrane while DAG activates pro-
tein kinase C (PKC) [112]. In turn, PKC phosphorylates AMPA receptors increasing 
their conductance to sodium ions resulting in the potentiation of the synapse [115].   
2.4.5 Paired Pulse Facilitation 
Paired pulse facilitation is a short term enhancement of a synapse on a time scale of 
hundreds of milliseconds. It is primarily considered to be a presynaptic phenomenon 
in which a second postsynaptic potential is enhanced relative to the first if the se-
cond potential quickly follows the first. The enhancement is considered to be the re-
sult of a transient increase in calcium levels in the presynaptic terminal resulting 
from the first pulse [116, 117]. The ratio of the second pulse compared to that of the 
first is used to determine if facilitation or depression took place, which both are con-
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sidered short term forms of synaptic plasticity. A PPF ratio greater than that of 1 in-
dicates that the synapse has under gone facilitation whereas all ratios blow that of 1 
are an indication of synaptic depression. The rational of PPF is twofold: first the activ-
ity of the presynapse determines the extent of transmitter release which in turn de-
termines the amount of activation at the postsypase (first pulse); second, the residu-
al calcium level in the presynaptic cell determines the magnitude of the second 
paired pulse in relation to the first pulse (second pulse). This gives rise to the necessi-
ty to determine the intensity of the first pulse as well as the time frame between the 
first and second pulses [117].  When PPF is induced following LTP, it is controversially 
considered to be indicative of whither LTP occurred pre- or postsynaptically as re-
ports are conflicting [118, 119].     
2.5 Plateau Firing 
Plateau firing, also referred to as plateau potential, persistent activity, or persistent 
firing, is a phenomenon in which single cells repeatedly fire action potentials for a 
sustained period following initial induction. It is believed to be a cellular mechanism 
for maintaining working memory as well as performing cognitive processes such as 
reward based decisions [120, 121]. Currently there are two concepts for how persis-
tent firing occurs, either intrinsically through a calcium activated nonspecific cation 
current or by reverberations in neuronal networks providing reciprocal positive 
feedback [122, 123]. Neurons which display intrinsic firing have been shown to 
demonstrate graded firing levels in direct response to depolarizing and hyperpolariz-
ing pulses which can either increase or decrease firing frequency respectively [9, 
124]. It is currently believed that the mechanism underlying graded firing exists of 
two opposing calcium dependent currents with differing calcium concentration 
thresholds. In normal conditions, the calcium activated potassium current (KCa) ex-
ceeds that of the calcium activated nonspecific cation current (CAN) so that persis-
tent firing does not occur. When the initial stimulus is strong enough, calcium influx 
can surpass a necessary threshold for CAN activation and persistent firing will take 
place. Spiking can be further increased by increasing CAN conductance with a second 
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stimulus and greater calcium influx. Firing can be degraded or ceased by membrane 
repolarization and reducing CAN conductance and replacing the KCa current above 
the CAN current. It is believed that biochemical processes such as phosphorylation 
and dephosphorylation set calcium threshold levels. Entry of calcium through voltage 
gated channels during action potential firing is essential for maintaining the CAN cur-
rent but insufficient to increase CAN conductance providing stable levels of firing 
[121, 122].      
2.6 The Amygdala 
The amygdala is a structurally and functionally heterogeneous collection of nuclei 
that is classically viewed to be the “emotional center” of the brain. First being identi-
fied and named by Friedrich Burdach [125], it is still under some controversy over its 
actual existence as a structure [126]. The amygdala is composed of two primary 
complexes, the centralmedial; containing the central (Ce) and medial (Me) nuclei and 
the Basolateral complex (BLA); which contains the lateral (La), basolateral (BL), ba-
somedial (BM), and basoventral (BV) nuclei [127, 128]. Growing from the ground-
breaking work of Pavlov [129], the amygdala has been considerably connected to 
conditioning, primarily that of fear, and emotional behavior [130-134]. As of late, 
more understanding is emerging in the relationship of the amygdala and memory, in 
particular consolidation [1, 33, 135, 136], and that of cognition [137-141].      
2.6.1 Connectivity 
Vast sensory input arrives at the amygdala from advanced levels of visual, auditory, 
and somatosensory cortices. The olfactory system and polysensory brain regions, 
such as the parahippocampal gyrus and the perirhinal cortex, also project profusely 
to the amygdala [142, 143]. The primary target of sensory input is the La while pro-
cessing of this information emerges almost exclusively in the BL via intrinsic connec-
tions between the two nuclei [144, 145]. Projections from the amygdala target a 
wide sphere of structures including the prefrontal cortex (PFC), striatum, sensory 
cortices, hippocampus, perirhinal cortex, entorhinal cortex, as well as the basal fore-
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brain. The amygdala also targets subcortical structures that are related to physiologi-
cal responses such as autonomic and hormonal [146]. Subcortical projections origi-
nate in the Ce while projections to cortex and striatum arise from the BL [147].  
2.6.2 Learning and Memory 
Learning of new information and the ability to recall this information later is crucial 
for survival. A single acute traumatic experience can induce an intense life long 
memory which is dependent upon BLA activation [148]. Stressful and emotional 
events are well remembered and it is believed that hormones and neurotransmitters 
released during such events are responsible for the enhanced memory formation [1]. 
The infusion of epinephrine, norepinephrine or corticosterone enhances memory 
while lesions of the BLA block this enhancement [149]. Intra amygdala infusions of 
cholinergic agonist and antagonist enhance and inhibit, respectively, memory in-
duced via many forms of behavioral animal training [150]. Stress hormone induced 
amygdala memory enhancement is also dependent upon cholinergic activation as 
muscarinic antagonist blocks such effects [151]. It has been shown that lesions of the 
BLA or its efferents severely impair learning and memory consolidation but do not 
extinguish such learning, thus indicating that the amygdala modulates other brain 
regions and is not the primary memory locus [152, 153]. In this regard, amphetamine 
infused into the caudate nucleus enhanced memory of visual cued training while 
amphetamine infused into the hippocampus enhanced spatial memory, yet amphet-
amine infused into the amygdala was able to enhance both types of memory. Inacti-
vation of either the hippocampus or the caudate nucleus with lidocaine blocked spa-
tial or visual memory respectfully, but amygdala inactivation had no effect on either 
memory type [153]. BLA electrical stimulation also modulates hippocampus LTP [154] 
and enhances induction of LTP in the dentate gyrus [155] while BLA lesions block the 
induction of LTP in the dentate gyrus [156]. Not limited to inducing strong amygdala 
activation, acute stress, as well as chronic stress, induces plasticity changes within 
the amygdala and thereby making the amygdala oversensitive to future stressful 
stimuli [157-159]. This enhanced amygdala response due to plasticity changes leads 
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to increases in anxiety, mood related disorders, as well as severe emotional disorders 
such as post-traumatic stress [160].             
2.7 p75 Neurotrophin Receptor  
The p75NTR is the first member of the tumor necrosis factor receptor (TNFR) super-
family to be characterized and is structurally characterized as having four, tandemly 
arranged,  cysteine-rich, extracellular domains consisting of a sequence of 40 amino 
acids and an intracellular death domain [161, 162]. p75NTR has the ability to bind all 
neurotrophins with low affinity but only NGF, BDNF and NT-4 have been shown to 
induce signaling [163-165]. A characteristic of p75NTR which distinguishes it from oth-
er TNFRs is the existence of a disulfide linked dimer formed via cysteinyl residues 
within the transmembrane domains. These transmembrane domains are necessary 
for p75NTR interaction with other neurotrophin receptors (NTRs) [166, 167].  
2.7.1 p75NTR signaling 
Paradoxically, activation of the p75 neurotrophin receptor has the ability to promote 
neuronal survival as well as induce apoptosis. For general purposes, it is accepted 
that lone activation of p75NTR induces apoptosis while the synergetic activation of 
p75NTR with another NTR promotes survival [168].  Upon binding NGF, p75NTR forms a 
asymmetric complex which allows interaction with only one tyrosine kinase receptor 
such as TrkA and thus, improving the affinity of TrkA to NGF [169]. p75NTR is cleaved 
by α-secretase freeing the extracellular domain preventing the further binding of 
neurotrophic factors, however the transmenbrane domain is still able to interact 
with tyrosine kynase receptors. Following α-secretase cleavage, p75NTR is further 
cleaved by γ-secretase freeing the intracellular domain which is then translocated to 
the cell nucleus. Surprisingly, NGF binding to p75NTR inhibits γ-secretase cleavage 
[170]. Interestingly it has been discovered that the precursors to mature neu-
rotrophic factors also bind to p75NTR inducing apoptosis, so far this has been shown 
to be the case for proNGF as well as proBDNF [171]. However, the most striking 
p75NTR signaling is that the cleaved intracellular tail has been shown to induce apop-
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tosis autonomously [172].  Aside from inducing apoptosis and promoting cell surviv-
al, p75NTR is also capable of regulating neurite growth, reduction, and repair [173]. 
Signaling induced by p75NTR can best be surmised as being dependent on the activat-
ing ligand as well as p75NTR ‘s promiscuity as a coreceptor.    
2.7.2 p75NTR transgenic mice 
There currently exist two forms of transgenic mice with regard to p75NTR. The first 
mouse was produced by deleting 3 of the 4 cysteine-rich extracellular domains by 
targeting exon III of the locus. This prevented the ability of p75NTR to bind any neu-
rotrophic factors; however the deletion left the transmembrane and intracellular re-
gions. This shorten formed of the receptor was termed s-p75NTR and was revealed to 
be coexpressed with the full length receptor at lesser quantities during embryonic 
development. Therefore, exon IV of the p75NTR locus was deleted to give a full abla-
tion of the receptor. Transgenic mice expressing the truncated s-p75NTR receptor are 
referred to as p75EXIII while mice with a complete ablation of the receptor are called 
p75EXIV [174]. Unfortunately it has been shown that the exon IV transgenic mouse al-
so displays a truncated version of the receptor which is capable of signaling [175]. 
Figure 2.7.1 | p75NTR Locus The full length (upper) and short (lower) forms of the p75
NTR
 locus. Above the loci 
are the corresponding exon domain numbers. In the truncated locus, domain III is deleted leaving behind the 
first 2 extracellular domains, the transmembrane and intracellular domains. The short locus is left behind in 
p75
EXIII
 mice whereas p75
EXIV
 mice are thought to be lacking both forms  
2.7.3 Known p75 deficits 
Mice lacking the exon III or exon IV region of the locus show specific phenotypes and 
deficits. Lesioning of neurons expressing the p75 receptor by various methods such 
as 192-IgG injections also leads to specific deficits related to the loss of the low affini-
ty nerve growth factor receptor. Exon IV animals show mobility problems due to hind 
limb ataxia [174], which also hampers the ability for nullizygous male mice to breed 
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(own observations) as well as a thinning of blood vessels resulting in fewer births of 
ko animals [174]. Both transgenic mouse lines show an increase in target innervation 
by cholinergic afferents as well as an increase in cholinergic neuronal size; interest-
ingly the number of cholinergic neurons is reduced [7, 174]. Aside from deficits in 
neuronal development, a loss of the receptor or the lesioning of neurons which ex-
press it greatly interferes with varying forms of learning and memory [176-179].   
Most studies concerning the loss of the p75 receptor and changes in plasticity have 
been performed in hippocampus. p75EXIV animals have demonstrated an impairment 
in LTD maintenance but no difference in LTP when induced by Schaffer collateral 
stimulation and recorded in region CA1. The mice also showed alterations in AMPA 
receptor subunits GluR2 and GluR3 [180]. It was further reported that signaling of 
proBDNF via p75NTR enhanced LTD in hippocampus and p75 ko animals showed re-
duced expression of NMDA receptor subunit NR2B which is uniquely involved in LTD 
[181].     
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Table 2.7.1 | Phenotype of p75NTR-deficient mice 
Cell population Phenotype 
Dorsal root gan-
glia 
Reduced neuronal survival due to impaired trkA signaling 
Failure of Schwann cells to migrate and related effects on axonal growth 
Basal forebrain Increased cholinergic neuron size, neurotransmitter expression and axonal 
branching in the adult, Increased/decreased cholinergic neuron number (contro-
versial) 
Superior cervical 
ganglia 
Increased neuron number during period of developmental cell death 
Retinal ganglia 
neurons 
Increased neuron number during period of developmental cell death 
Trigeminal neu-
rons 
Increased neuron number during period of developmental cell death 
Spinal motor neu-
rons 
Increased neuron number during period of developmental cell death 
Facial motor neu-
rons 
Increased survival following axotomy 
Hippocampal neu-
rons 
Increased survival after seizure, Increased dendritic branching and spine density, 
Altered LTD 
Spiral ganglion 
neurons 
Progressive hearing loss 
Subventricular 
zone 
Reduced adult neurogenesis 
Vasculature Thinner blood vessels 
Hepatic stellate 
cells 
Inhibited hepatocyte proliferation, and liver regeneration 
Alternative splice 
forms 
Low levels of an extracellularly truncated death-inducing protein are expressed 
on certain congenic backgrounds in each of the two strains 
Summary of the phenotype displayed by transgenic mice for the p75 neurotrophin receptor adapted from Un-
derwood et al 2008 [182] 
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3 Objectives 
The amygdala plays a substantial role in learning and memory and is a key regulator 
of memory consolidation. It also displays one of the highest cholinergic densities in 
the brain; as such, it was desired to elucidate differences in plasticity based upon 
cholinergic innervation of the BL and La nuclei of the amygdala. Since the vast major-
ity of cholinergic projection neurons in the substantia innominata also display the 
p75 neurotrophin receptor, and it has been shown that ko animals for p75NTR show 
significant augmentation of cholinergic innervation, plasticity differences in p75EXIV 
mice were also studied.   
ChAT immunohistochemistry was used to determine cholinergic innervation differ-
ences between the BL and La as well as a determination of stimulation and recording 
sites for electrophysiological experiments. 
Field potential recordings and sharp microelectrode recordings were used to deter-
mine if differences in cholinergic density plays a role in plasticity in the La and BL 
amygdala nuclei. 
LTP was used to determine if p75EXIV animals had an enhancement of LTP related to 
increased cholinergic innervation.  
Field potential recordings were conducted to study differences in the amygdala be-
tween p75EXIV ko and wt animals and if the variation in cholinergic fiber density plays 
a role. 
Paired Pulse Facilitation was used to elucidate any change in presynaptic transmitter 
release as well as possible changes in cholinergic mediated presynaptic inhibition be-
tween p75EXIV mice and wt animals.  
Biocytin staining was used to complement electrophysiological neuronal characteri-
zation as a further determination of projection neurons based upon their morpholo-
gy.  
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4 Materials 
4.1 Electrophysiology 
4.1.1 Equipment 
A.M.P.I. Master 8 programmable stimulator 
ISO-flex stimulus isolator 
A.M.P.I.  
Hameg HM507 50 MHz CombiScope  
oscilloscope 
HAMEG Instruments GmbH 
Axon Instruments AxoClamp 2B amplifier with remote 
buzzer  
two  HS-2A-x0.1LU head stages 
Molecular Devices 
CED Micro 1401 mk 2 data acquisition unit 
Spike2 and Signal software 
Cambridge Electronic Design Lim-
ited 
Gilson Miniplus3 Peristaltic Pump  
with 2 channel head 
Gilson, Inc. 
NI EMPS-07 modular housing 
two DPA-2FS filters 
npi electronic GmbH 
FST Interface Recording Chamber 
TR-200 temperature regulator 
Fine Science Tools GmbH 
Schott KL 1500 LCD cold halogen lamp SCHOTT AG 
Askania SMT4 stereomicroscope  
with stand 
Mikroskop Technik Rathenow 
GmbH 
Siskiyou manual micromanipulator  
SD-MX110R 
SD-MGB 3.0 base 
SD-MX630R hydraulic drive 
Siskiyou Corporation 
Märzhäuser MM33 manual 
micromanipulators with base 
Märzhäuser Wetzlar GmbH & Co. 
KG  
Active Air Suspension Isolation Table including 
working plate granite with stainless steel top 
Steel Faraday Cage 
Borosilicate glass microelectrodes with  
filament 
Science Products GmbH 
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Sutter Instrument P-97 Flaming/Brown 
Micropipette Puller 
Sutter Instrument Company 
Exadrop precision gravity infusion B. Braun Melsungen AG 
Bipolar stainless steel electrode Rhodes Medical Instruments Inc. 
Flexible silicone rubber heater Minco Worldwide Headquarters 
Nanoliter 2000 Injector World Precision Instruments 
Slice Holding Chamber University of Heidelberg 
4.1.2 Slice Preparation 
Non-Sterile Scalpel Blades #20 
Non-Sterile Scalpel Blades #10 
Standard Pattern Scissors- Large Loops 
sharp/blunt 14.5cm 
Scalpel Handle #4- 13cm 
Extra Thin Iris Scissors- 10.5cm 
Scalpel Handle #3- 12cm 
Spring Scissors- 10mm Blades Angled   Side 
Dumont #7b Medical Forceps- Inox Standard Tip 
Halsted-Mosquito Hemostats- 12.5cm 
Dumont #7 Forceps- Titanium Biologie 
Dumont #2AP Forceps- Inox Epoxy Coated 
Dumont #5 Mirror Finish Forceps- Inox Biologie 
Fine Science Tools GmbH 
Pattex Blitz Pinsel Henkel KGaA 
Multifix razor blades Apollo Herkenrath GmbH  
& Co. KG 
Vibroslice MA752 Campden Instruments 
4.1.3 Gas Assembly 
Carbogen (95% O2 5%CO2) 
Compressed air 
Air Liquide 
PUN 6x1BL pneumatic tubing Festo 
Tygon tubing LabMarket GmbH 
Couplings and adapters neoLab Migge Laborbedarf-Vertriebs 
GmbH 
Messer 3-O-200 BG88 and 3-D-200 Pressure regu-
lators 
Messer Group GmbH 
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4.1.4 Chemicals 
Apamin 
UCL 1648 
2-APB 
APV (AP-5) 
Atropine 
Kynurenic Acid 
Eserine (Physostigmine) 
CNQX 
Picrotoxin (Cocculin) 
Biocytin 
Carbachol 
Glucose 
Sigma-Aldrich 
NaCl J.T. Baker Inc. 
NaHCO3 
KCl 
CaCl2 
MgSO4 
Carl Roth GmbH + Co. KG 
NaH2PO4 Grüssing GmbH 
4.2 Genotyping 
4.2.1 Equipment 
Mastercycler PCR cycler 
Thermomixer comfort 
Eppendorf AG 
Alphaimager mini gel  
documentation system 
Alpha Innotech 
PowerPac 300 Bio Rad Laboratories 
EasyPhor gel chamber Biozym Scientific GmbH 
Thermo printer P93DW Mitsubishi  
Vortex Genie 2 Scientific Industries 
4.2.2 Primers 
Mp75Ex4-S3 
5'-TGT-TGG-AGG-ATG-AAT-TTA-GGG-3' 
Metabion International AG 
2590 
5'-GAT-GGA-TCA-CAA-GGT-CTA-CGC-3' 
Pgk-2 
5'-AAG-GGG-CCA-CCA-AAG-AAC-GG-3' 
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4.2.3 PCR 
QuickExtract DNA Extraction Solution EPICENTRE Biotechnologies 
Platinum Taq DNA Polymerase 
10X PCR buffer 
 50 mM MgCl 
100 mM dNTP set 
TrackIt  50 bp DNA Ladder 
TrackIt  Cyan⁄Orange Loading Buffer 
Invitrogen 
4.3 Immunohistochemistry 
4.3.1 Equipment 
Leica VT100 S vibrating blade microtome Leica Microsystems 
Super Frost Plus slides R. Langenbrinck Labor und Medizintechnik 
Axioplan2 Imaging Zeiss 
Axiocam HRc Zeiss 
Stretching Table OTS 40 Medite GmbH 
4.3.2 Markers 
DAPI Boehringer 
Alexa Fluor Molecular Probes 
ChAT Chemicon 
Biotinylated IgG Vector Laboratories 
Streptavidin Cy3 Jackson ImmunoResearch 
4.4 Solutions 
50x TAE buffer 
242 g Tris  
57.1 ml acetic acid 
100 ml 0,5 M EDTA (pH 8)  
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1x PBS 
8 g NaCl  
0.2 g KCl  
1.15g Na2HPO4   
0.2 g KH2PO4  
to 1 L distilled water 
 
0.1 M PB 
2.62 g NaH2PO4  
14.41 g Na2HPO4  x 2 H2O  
to 1 L distilled water 
 
4% PFA 
40 g PFA 
to 1 L 0.1 M PB 
 
Mowiol 
2.4 g Mowiol  
6 g Glycerol  
6 ml Distilled water 
12 ml 0.2M Tris (pH 8.5) 
 
3% HS 0.3% Triton in PBS 
6 ml HS 
0.6 ml Triton 
to 200 ml with PBS 
 
Ringer 
NaHCO3  26 mM 
KCl  3 mM 
CaCl2  1.6 mM 
MgSO4  1.8 mM 
Glucose  10 mM 
NaCl  124 mM 
NaH2PO4  1.25 mM 
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5 Methods 
5.1 Electrophysiology 
5.1.1 Slice Preparation 
Acute horizontal brain slices were prepared from adult mice following decapitation 
under diethyl-ether anesthesia. The brain was then rapidly removed and placed into 
ice cold artificial cerebral spinal fluid (aCSF) saturated with carbogen gas. After an 
incubation time of 20 minutes, the brain was then hemisected in the midsagittal 
plane and the cerebellum was removed.  It was then cut dorsally 30 degrees from 
rostral to caudal and fixed along this edge with a cyanoacrylate adhesive (Pattex Blitz 
Pinsel) to the cutting block so that the brain was sitting oblique to the block surface 
with the ventral side upward and the hemisections facing another caudally. The cut-
ting block was then submerged in ice cold aCSF saturated with carbogen and 400µm 
thick horizontal sections, containing the hippocampus, amygdala, entorhinal and 
perirhinal cortices and substantia innominata, were then cut using a Campden vi-
broslicer from lateral to medial. Horizontal slices were then placed into a holding 
chamber (built in house) and incubated for at least one hour, after which slices were 
transferred to an interface recording chamber (FST) and held at 33° C ±1 degree for 
at least another hour. 
5.1.2 Electrophysiological Recording 
Horizontal slices were placed in an interface recording chamber (FST) and allowed to 
accumulate at least for one hour to continuous profusion of aCSF at a rate of 2 ml 
min-1 and a temperature of 33° C ±1 degree. Extracellular field potential recordings 
were then recorded using an Axoclamp-2B amplifier (Molecular Devices) in conjunc-
tion with a DPA-2FS extracellular amplifier (npi Electronics). Signals were filtered on-
line at 1 kHz and digitized at 5–10 kHz by an analog to digital computer interface 
(CED) and then were stored using Spike2 software (CED). Field potential (fp) record-
ings were obtained with aCSF filled borosilicate glass electrodes with a tip resistance 
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of 1 MΩ placed in either the La, BL or both of the amygdala which was identified with 
a dissecting microscope using trans-illumination.  An extracellular bipolar electrode 
(Rhodes Medical Instruments) was used to induce synaptic fp responses by local 
stimulation of the external capsule. Pulses (0.1 ms, 4–25 V) were delivered with an 
Iso-Flex stimulus isolator (AMPI) triggered by a Master-8 pulse generator. 
For LTP induction, an input/output (I/O) response curve was constructed by varying 
the intensity of single-pulse stimulation and then averaging 6 responses at each in-
tensity. The stimulus intensity that evoked a mean fp equal to 50% of the maximum 
amplitude was then used for all subsequent stimulations (duration: 0.1 ms frequen-
cy: 0.1 Hz). A stable baseline was obtained by presenting a single stimulus (100 µs 
duration) every 10 seconds. Once a stable baseline of responses was obtained for at 
least 20 min, HFS was delivered as 2 trains at a frequency of 100 Hz (duration: 1 s, 30 
s apart). Drug-induced changes in baseline activity were considered. Subsequent re-
sponses to single stimuli were recorded for at least 60 min, and their amplitude was 
quantified as percent change with respect to baseline. 
Paired Pulse Facilitation (PPF) was performed by delivering 2 pulses (duration: 0.1 ms 
frequency: 0.1 Hz) with an inter-stimulus interval (ISI) of 10 to 100 ms and a stimula-
tion intensity which evoked a potential equal to 50% of the maximum amplitude fol-
lowing an I/O curve and baseline. The amplitude of each pulse was quantified as per-
cent change to baseline or as a ratio between the second and first pulse. Pulses were 
delivered in PPF and LTP paradigms as already stated in the extracellular methods as 
well as placement of the stimulator and recording electrodes see Fig. 6.2.1 in Results 
section and Fig. 11.1.2 appendix.  
Intracellular recordings were obtained using sharp microelectrodes pulled on a 
Brown-Flaming puller P-97 (Sutter Instruments) from 1.5-mm borosilicate glass with 
filament and backfilled with 2 molar potassium-acetate resulting in a tip resistance of 
60– 120 MΩ. Signals were amplified using an Axoclamp-2B amplifier and were digital-
ly stored using Spike 2 laboratory software (CED). Intracellular potentials were rec-
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orded in bridge mode and the bridge balance was monitored and compensated 
throughout the experiments. Resting membrane potential was determined by sub-
traction of the tip potential following withdrawal from the cell. Input resistant was 
calculated by current injections (intensity: 0.2 to 0.4 nA duration: 200 ms) through 
the recording electrode and measuring the resultant voltage deflections. Membrane 
potential was manually adjusted by intracellular injection of DC current through the 
recording electrode and holding recorded cells to near firing threshold when eliciting 
persistent activity. An extracellular bipolar electrode was used to induce synaptic re-
sponses by stimulation of the substantia innominata (SI) or within the BLA. Trains of 
pulses (0.1 ms, 5–20 V) were delivered at 10–100 Hz for 0.1–10 s with an Iso-Flex 
stimulus isolator (AMPI) triggered by a Master-8 pulse generator. 
Plateau firing was induced using a standard paradigm [124]. In the presence of 10 
µM carbachol, cells were held near AP threshold and a suprathreshold 4 s 0.3 to 0.4 
nA pulse was given to induce plateau firing. Alternatively, 1 µM eserine was bath ap-
plied and an extracellular bipolar electrode was used to stimulate cholinergic SI af-
ferents. The cell was either held near AP threshold and SI stimulation (10 Hz) was 
used to induce plateau firing or while the cell was at VM rest, repeated SI stimulation 
was given once every 30 s at 10 to 50 Hz to induce plateau firing. SI stimulation 
strength was always subthreshold and was given between 8 and 14 mV with 10 mV 
and 10 Hz being the most prevalent.          
5.1.3 Biocytin Neuronal Labeling 
During intracellular recordings some neurons were labeled with biocytin in order to 
elucidate cell morphology. Sharp microelectrodes were prepared as previously stated 
with the exception that the tips were first filled with biocytin and then the electrodes 
were back filled with 2 molar potassium acetate. Biocytin was prepared by dissolving 
in Milli-Q water. Following experimental recordings, biocytin was injected using puls-
es of positive and negative current at 0.4 nA with a varying duration of 10 to 200 ms. 
Slices were left in the interface chamber, after current injections, for a minimum of 
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20 minutes to allow biocytin to diffuse throughout the cell arborization. Slices were 
then removed from the interface chamber and placed into 4% PFA in PB overnight at 
4° C. 
5.1.4 Data Analysis 
Extracellular data were collected and averaged with Signal 2 software (CED). Field 
potential amplitude was defined as the absolute DC voltage of a vertical line running 
from the minimal point of the fp to its intersection with a line running tangent to the 
points of fp onset and offset. It is assumed that the recorded negative wave reflects a 
summation of both excitatory post-synaptic potentials and synchronized action po-
tentials (population spike component) [183, 184] Watanabe et al. [184] have carried 
out intracellular recordings of evoked potentials and confirmed that the latency of 
peak negative fps (5–6 ms) corresponds well with that of intracellular recorded ac-
tion potentials, indicating that the extracellular recorded sharp negativity is a popula-
tion spike. Therefore, the amplitude of fps was analyzed. In addition, the slope 
measure in the lateral amygdala is more sensitive to variability and signal noise, mak-
ing it difficult to analyze [183]. To calculate the significance of differences between 
groups, the Mann-Whitney test was primarily used (GraphPad Prism). P < 0.05 was 
considered significant. Where the Mann-Whitney test (2 groups, one factor) was not 
applicable then either Kruskal-Wallis (3 or more groups, one factor) or Two-way 
ANOVA (3 or more groups and 2 or more factors) were performed with their appro-
priate posttest. To express and compare changes of fp amplitudes between groups in 
LTP paradigms, the averaged responses from either the 20 to 30 or 50 to 60 min pe-
riod after HFS were used. PPF responses were analyzed by a ratio comparison of the 
averaged signals of pulse 2 to pulse 1 [(P2 - P1 x 100%)/P1] and plotted as a ratio of 
pulse 2 to pulse 1. All data are shown as mean ± sem unless otherwise stated. 
Intracellular data were analyzed offline using Spike 2 software (CED). The amplitude 
of the SI afferent stimulus induced deflection was measured in relation of the mem-
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brane potential and presented as mean ± sem. Peristimulus histograms were per-
formed using Spike 2 as needed.  
5.2 Immunohistochemistry 
5.2.1 Biocytin Development 
Slices were stored overnight in 4% PFA in PB then transferred to a 24 well plate. Slic-
es were washed using 1% PBS, repeated 3 times for 5 minutes each wash. Incubation 
for 2 hours at room temperature was then performed using Streptavidin-Cy3 in PBS 
(concentration: 1:1500-1:2000, volume: 250-500 µl/well). Slices were then rewashed 
with PBS, as stated, followed immediately by a counter stain with DAPI (concentra-
tion 1:100000) for 2 minutes at room temperature. Two washes, in PBS as previously 
mentioned, were then conducted followed by a quick wash in Milli-Q water for 30 
seconds. Slices were then allowed to dry and were mounted and cover-slipped using 
Mowiol on a glass slide.  
5.2.2 ChAT Staining 
Animals were transcardially perfused with PBS followed by 4% PFA. The brain was 
then removed and stored in 4% PFA at 4° C. Horizontal slices with a thickness of 25 to 
40 µm were cut on an automated, vibrating, blade microtome (Leica Microsystems) 
and collected in PB solution. Slices were then washed 3 times in PBS for a period of 5 
minutes each wash followed by membrane permeabilization with 0.4% Triton-X 100 
in PBS for 30 minutes. Slices were re-washed, as stated above, and a blocking solu-
tion consisting of 3% horse serum and 0.3% Triton-X in PBS was applied for the dura-
tion of 1 hour. A repeated wash cycle as stated was performed followed by incuba-
tion with ChAT antibody (concentration: 1:100 in 1% HS|0.1% Triton-X|PBS) for a 2 
day period at 4° C. Again a wash cycle was executed on the slices and incubation with 
the secondary antibody at a concentration of 1:1000 was carried out either over 
night at 4° C or at room temperature for 5 hours. Following secondary antibody incu-
bation, slices were re-washed and counterstained with DAPI (1:100000) for 2 
minutes. A final wash (3 X PBS and 1 X Milli-Q water) was administered and slices 
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were then dried and mounted on glass slides with Mowiol. Alternatively, in order to 
strengthen fidelity in small fiber tracts, in place of the normal secondary antibody a 
biotinylated antibody was used (concentration: 1:2000, incubation: 2 hours RT). Slic-
es were then washed as previously stated proceeded by incubated with Streptavidin-
Cy3 (1:2000) for 2 hours at room temperature. The regular protocol was then fol-
lowed until mounting. Staining was carried out using a free floating technique and a 
volume of 500 µl for all steps. 
5.2.3 ChAT Analysis 
Slices were observed and photographed using an Axoplan 2 microscope coupled to 
an Axiocam HRc digital camera (Zeiss). RGB images were then analysed using ImageJ 
software (NIH). Areas corresponding to the BL and La nuclei were manually selected 
according to brain atlases [185, 186] and RGB pixels were converted into intensity 
values based upon the formula V=(R+G+B)/3 using standard weighing (R=0.299, 
G=0.587, B=0.114). The Mann-Whitney test was used to determine statistical differ-
ence and data are reported as mean ± sem. Photos were merged, when applicable, 
and adjusted for contrast and brightness using Adobe Photoshop CS4 for presenta-
tion. All analyses were performed on unedited images and images were obtained us-
ing a calibrated standard conducted on multiple slices.    
5.3 Mice 
p75EXIV mice, which were originally created in a 129/SvJ strain and backed crossed 
into a C57/BL6 strain, were bred in house. Homozygous, heterozygous and wild type 
animals were maintained. Wild type C57/BL6 animals were ordered via normal sup-
pliers. p75EXIV animals were originally provided by Prof. Dr Yves-Alain Barde (Universi-
ty of Basel, Switzerland).    
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5.4 Genotyping 
5.4.1 DNA Extraction 
Tail tips obtained from experimental animals were used for DNA extraction. The tails 
were placed into 1.5 ml microcentrifuge tubes and 200 µl of QuickExtract DNA Ex-
traction Solution 1.0 was added to each tube. The tubes were then vortexed for 15 
seconds and placed into a thermomixer pre-heated to 65° C and incubated for 6 
minutes. Following initial incubation, the tubes were again vortexed for 15 seconds 
and a final incubation was carried out at 98° C for 2 minutes. Genomic DNA was then 
stored at -20° C or immediately used for PCR. 
5.4.2 PCR 
Due to the incompatibility of the primers for genotyping, two PCR reactions were 
created for each DNA sample. A master mix was created with the following compo-
nents according to manufacturer’s protocol: Taq DNA Polymerase, MgCl2, dNTPs, PCR 
reaction buffer, primers (mix A: 2590/Mp75Ex4-S3, mix B: 2590/Pgk-2), and sample 
DNA. The reactions were then filled with the necessary amount of pure water for ei-
ther 20 µl or 50 µl reactions. PCR was then carried out using the following program:  
CNTRL TUBE 
1. HOLD 95° C  ENTER 
2. T=95° C 0:03:00 
3. T=95° C 0:00:30 
4. T=58° C 0:00:30 
5. T=72° C 0:01:00 
6. GOTO 3 REP 39 
7. T=72° C 0:10:00 
8. HOLD 6° C ENTER 
END  
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5.4.3 Gel Electrophoresis 
A 1.5% agarose solution was created by adding 3 grams of agarose to 200 ml of 1% 
TBE buffer and heating in a microwave. The solution was allowed to cool for approx-
imately 10 minutes allowing the addition of ethidium bromide. The solution was then 
poured into a gel electrophoresis chamber and allowed to solidify. 10 to 20 µl of am-
plified product was then pipetted in to the corresponding well for each product and 
the gel was then run for 1.5 to 2 hours. Visualization was then carried out under UV 
light and the gel was photographed for analysis.  
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6 Results  
6.1 Immunohistochemistry 
6.1.1 ChAT Staining 
Based upon observations in the literature as well as brain atlases [185, 186], it was 
decided that a horizontal slice preparation would be the best method for electro-
physiological studies. 25 to 40 µm horizontal slices from adult mice were incubated 
with a specific antibody for choline acetyltransferase and counterstained with DAPI 
to determine cholinergic cell and fiber locations. The slices included the hippocam-
pus, amygdala, entorhinal and perirhinal cortices and substantia innominata and 
were on the same plane as slices prepared for electrophysiology. Based upon ChAT 
immunohistochemistry, stimulation sites were determined for LTP, fEPSPs, and intra-
cellular electrophysiological studies. Differences in fiber density observed between 
the BL and La were also measured using ImageJ. 
ChAT immunohistochemistry showed a clear separation between the BL and La nu-
clei based upon cholinergic fiber density (Fig. 6.1.1). The stria terminalis also dis-
played reactivity against the ChAT antibody. Cholinergic neurons were observed cau-
dal medial to the BL nucleus of the amygdala corresponding with the area of the sub-
stantia innominata which is also the location of the nucleus basalis of Meynert. ChAT 
positive fiber tracts could be observed between that of the SI and the BL nucleus; fi-
bers of the External Capsule were also distinguishable and showed limited ChAT re-
activity.  
  
Results 
Cline 2010 38 
Figure 6.1.1 | ChAT Immunohistochemistry Immunohistochemistry in 25 µm horizontal slice preparation. (A) 4 
X collage of horizontal slice showing SI, substantia innominata; BL, basolateral; La, lateral; and LV, lateral ven-
tricle. Arrows indicate the fiber tract of the external capsule. (B) 10 X of cholinergic neurons located in the SI, 
source of amygdala cholinergic innervation. (C) 4 X showing cholinergic fibers as well as cholinergic neurons 
originating in the SI and projecting to the amygdala. Arrows indicate cholinergic afferents and neuron. Scale 
bars for A and C are 100 microns and 50 microns for B. 
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Measurement of intensity using ImageJ software revealed a highly significant differ-
ence for ChAT reactivity between that of the BL and La amygdala nuclei as revealed 
by the Mann-Whitney test (Fig. 6.1.2). The mean intensity for the BL and La were 
34.60 ± 1.057 and 27.47 ± 0.8166 (p ≤ 0.001) respectively. 
Figure 6.1.2 | ChAT Intensity (A) 25 µm horizontal slice showing areas measured for intensity using ImageJ 
software based on RGB color vectors and the formula V=(R+B+G)/3 with standard weightings of RGB. Arrows 
depict fibers of the EC. Scale bar equals 100 microns (B) Mann-Whitney test between La and BL of the BLA. 
Data is presented as mean ± sem.  
La: mean 27.47; sem, 0.8166 | BL: mean 34.60; sem 1.057 ***p < 0.001 N: 5 
6.2 Electrophysiology 
Based upon ChAT immuno-
histochemistry, it was decid-
ed that for field potential re-
cordings stimulation would 
be applied to the fiber tract 
of the external capsule while 
recording electrodes would 
either be positioned in the La 
or BL of the amygdala. Con-
trol experiments were then 
conducted to determine the best placement of the stimulating electrode in relation 
to the recording electrodes in order that a stable and reproducible signal could be 
Figure 6.2.1 | Horizontal Slice Diagram depicting the plane of the hor-
izontal slice preparation used for field recordings, PPF, and LTP and 
the approximate placements of stimulator and microelectrodes. Modi-
fied from Paxinos 1998 [186]  
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obtained. When the desired field excitatory postsynaptic potentials were sufficiently 
reproducible, preliminary experiments were then performed to determine if EC fiber 
stimulation could elucidate a cholinergic modulation of the fEPSPs.  
6.2.1 Effect of Atropine and Eserine on fEPSPs 
Since ChAT immunohistochemistry revealed a significant difference between the BL 
and La of the amygdala for cholinergic innervation, fEPSPs were recorded in both nu-
clei during cholinergic challenge in order to show a physiological difference as well. 
Excitatory postsynaptic field potential recording did not reveal any differences be-
tween the BL and La with or without cholinergic challenge (Fig. 11.1.1, appendix); 
therefore, data from both nuclei were combined. Cholinergic challenge did however 
significantly alter the field potential as can be seen in figure 6.2.2.   
Figure 6.2.2 | Cholinergic challenge of fEPSPs Field potentials initiated with a stimulus which produced an 
amplitude 50% of maximum. (A) 10 µM atropine caused a potentiation of the fEPSP which reached a maximum 
at 20±5 minutes. 1 µM eserine inhibited the fEPSP reaching a maximum at 20±10 minutes. (B) Mann-Whitney 
analysis revealed a significant effect of atropine and eserine on the fEPSP. All drugs were bath applied. Data 
shown mean ± sem. Atropine: mean 250.6 ± 4.468 | Eserine: mean 47.48 ± 2.114 ***p ≤ 0.001 N: 5 
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Bath application of 10 µM atropine, a competitive selective antagonist of mAChRs, 
and 1 µM eserine, a slowly degraded inhibitor of AChE, were able to significantly po-
tentiate or inhibit fEPSPs respectively. EC fiber stimulation was given at a strength 
elucidating a postsynaptic potential equal to that of 50% of the maximum amplitude. 
Both atropine and eserine demonstrated a time dependent action on the fEPSPs (Fig. 
6.2.2). Application of atropine resulted in a gradual potentiation of the field potential 
and reached a maximum at approximately 15 to 20 minutes. Eserine inhibition of the 
field potential began at approximately around 5 to 15 minutes while a maximum ef-
fect was seen between 20 and 30 minutes. Eserine application of greater than 20 
minutes eventually resulted in the complete inhibition of the field potential signal. A 
physiological cholinergic difference for fEPSPs between the BL and La was not ob-
served; however, cholinergic antagonization or agonization did significantly either 
enhance or diminish the field potential respectively.   
6.2.2 Paired Pulse Facilitation 
Control experiments for PPF were first 
performed to determine the optimal in-
ter stimulus interval that should be used 
for subsequent cholinergic challenge. 
The ISI was varied from 10 to 100 milli-
seconds which elucidated a maximal fa-
cilitation at 40 ms (Fig. 6.2.3). A signifi-
cant difference was not observed be-
tween the lateral or basolateral nuclei 
of the amygdala and therefore data 
from both sites were combined. An ISI 
greater than 100 ms resulted in an ex-
ponential decrease in the paired pulse 
ratio and therefore were not conducted after initial pilot studies. Based upon the re-
sults obtained, it was decided that all subsequent experiments would be performed 
Figure 6.2.2 | PPF ISI paired pulse facilitation with 
varying inter stimulus intervals from 10 to 100 ms. at 
50% maximum amplitude. N: 3 
ISI (ms) mean sem ISI (ms) mean sem 
10 1.046 0.03114 60 1.431 0.02653 
20 1.353 0.02357 70 1.429 0.02347 
30 1.494 0.03729 80 1.465 0.01876 
40 1.591 0.02436 90 1.445 0.02988 
50 1.517 0.03851 100 1.394 0.03496 
 
Results 
Cline 2010 42 
using an ISI of 30 ms and a stimulation intensity which induced an amplitude for the 
first pulse consisting of 50% maximum. The chosen ISI and stimulus intensity would 
allow for facilitation/depression to occur but would not produce a ceiling/floor effect 
when challenged.  
Initial experiments demonstrated that eserine application was able to inhibit the 
field potential induced by EC fiber stimulation. Eserine inhibits the degradation of ac-
etylcholine in the synaptic cleft by blocking acetylcholinesterase and thereby allow-
ing the accumulation of ACh. During fiber stimulation in the presence of eserine, the 
amount of ACh in the synaptic cleft depends upon the frequency, duration and inten-
sity of the stimulation; due to this, it was decided to test the effect of carbachol 
(CCh), a non-selective AChR agonist which is resistant from AChE, on the field poten-
tial. This allowed for a more stable level of ACh at the synaptic cleft which could be 
manipulated with the concentration of CCh used. Paired pulse facilitation was im-
plemented to determine if the cholinergic effect was occurring pre- or post synapti-
cally. 
When paired pulses were delivered at a stimulus intensity of 50% maximum baseline 
it was observed with CCh as well as with eserine that the fEPSPs were abolished (Fig. 
6.2.4 A). In order to test if this was a true inhibition or a change in threshold, stimula-
tions of 2, 4 and 6 mV were given above initial baseline during CCh application (Fig. 
6.2.4 A, Fig. 6.2.5 D). At all carbachol concentrations the threshold was increased cor-
responding in relation to the concentration of CCh and this increased threshold was 
reversed with the application of atropine; however, atropine could not reverse the 
baseline inhibition of the fEPSP at 50% maximum amplitude. 
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Figure 6.2.4 | PPF with Carbachol challenge (A) Time course showing CCh inhibition of the fEPSPs. Stimula-
tions at 2, 4 and 6 mV above initial baseline were given to demonstrate an increase in firing threshold and not 
a complete inhibition of the field potential by CCh. Application of 10 µM atropine did not block the increased 
threshold. (B, C,D) PPF for stimulations at 2, 4 and 6 mV above baseline show that although CCh inhibited the 
fEPSP it increased the PPF ratio. CCh 0.5, 5 and 10 µM and atropine 10 µM were all bath applied. BL and La 
combined. N: 3 
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Since carbachol was able to severely inhibit the field potential at a baseline of 50%, 
which was irreversible with atropine, it was decided to use a baseline of 80% maxi-
mum amplitude. Carbachol was still able to significantly reduce the overall fEPSP 
amplitude but at the new baseline level atropine application was able to reverse this 
inhibition and induce potentiation (Fig. 6.2.5 A). The potentiation is in agreement 
with fEPSPs studies when atropine is applied alone. The reversal of the CCh induced 
inhibitions at 80% but not at 50% maximum amplitude also evidences an increased 
threshold as with the stimulus challenges in figure 6.2.4 A which showed significant 
differences with respect to CCh concentration as well as stimulus intensity as re-
vealed by Two-way ANOVA with Bonferroni posttest (Fig. 6.2.5 D). The paired pulse 
ratio was also increased with CCh in a dose dependent manner indicating a presyn-
aptic inhibition via mAChR activation as seen in figure 6.2.5 C. Paired pulse facilita-
tion shows that the enhanced field potential in the presence of atropine is due to the 
disinhibition of the presynapse while eserine and carbachol increase the PPF ratio by 
augmenting presynaptic inhibition as well as enhancing transmitter release for the 
second pulse. 
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Figure 6.2.5 | PPF with CCh challenge at 80% maximum  (A) Time course showing CCh inhibition of the fEPSPs. 
Application of 10 µM atropine was able to reverse the CCh inhibition and cause potentiation. (B, C) Kruskal-
Wallis analysis with Dunns Multiple Comparison Test showed a very significant and highly significant difference 
in the PPF ratio for CCh concentrations at 0.5 and 5 µM respectively N: 3. Atropine blocked the increased ratio. 
(D) Stimulations of 2, 4 and 6 mV above baseline to test effect of CCh on threshold baseline was at 50% maxi-
mum amplitude Two-way ANOVA with Bonferroni posttest revealed a highly significant difference between 
CCh and stimulus ***p < 0.001 N: 3 Bonferroni summary can be seen in table below (A, B, C) Baseline stimula-
tion was at 80% maximum amplitude All drugs were bath applied. BL and La combined. 
C Ringer 0.5 CCh 5 CCh 5 CCh+Atro 
mean 1.262 1.548 3.953 1.346 
sem 0.02125 0.02200 0.1986 0.02269 
p n/a ** *** Ns 
N=3     
     
D 2 mV 4 mV 6 mV 2 v 4 mV p 2 v 6 mV p 4 v 6 mV p 
0.5 CCh 36.35 82.31 104.7 *** *** * 
5 CCh 54.74 124.0 107.4 *** *** ns 
10 CCh 7.922 28.71 25.86 Ns ns ns 
10 + atro 112.4 212.1 182.3 *** *** ** 
N=3       
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6.2.3 Characterization of BL and La neurons 
Only neurons which had characteristics of typical projection neurons were measured 
[70]. Some cells were filled with biocytin (10 from 82) for morphological characteriza-
tion. 
Figure 6.2.6 | Characterization of neurons (A) Sample characterization of a typical BL neuron negative and 
positive current injection was given at 1,2, 3 and 4 nA 200 ms duration VM 76 mV (B) Biocytin filled neuron de-
veloped with a Streptavidin-Cy3 protocol. Picture displays only the R channel (RGB) and is adjusted for bright-
ness and contrast. Location of neuron was superficial in slice and found in BL nucleus. Scale bar is 25 microns 
6.2.4 BL neurons show persistent firing 
As it was already shown that neurons in the lateral amygdala nucleus were capable 
of producing persistent activity during cholinergic activation [9], it was decided to 
test this phenomenon in the BL which displays greater cholinergic fiber density. Ini-
tial experiments were first conducted in the presence of 10 µM carbachol and direct 
current injection to hold the cell membrane near firing threshold. A four second 
pulse was then delivered to induce plateau firing. In the presence of CCh using 
standard techniques, BL neurons showed persistent activity. Stimulation of choliner-
gic SI afferents in the presence of 1 µM eserine was then used to determine if persis-
tent firing could be induced in BL neurons via cholinergic synaptic activation. As in  
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Figure 6.2.7 | Persistent firing in BL neurons (A) Persistent activity induced with continuous DC injection to 
just below threshold and a 4 s 0.4 nA pulse in the presence of 10 µM CCh. N=27 (B) Persistent activity induced 
with DC injection to just below threshold and cholinergic fiber stimulation at 10 Hz followed by a 4 s 0.4 nA 
pulse in the presence of 1 µM eserine. N=23 (A,B) lower traces show direct current injection. All experiments 
were done during glutamatergic and gabaergic blockade using 2 mM kynurenic acid and 100 µM picrotoxin 
respectively. All drugs were bath applied. Starting VM for A and B was 71.2 and 73 mV respectively. 
CCh experiments, the cell was held just below firing threshold with direct current in-
jection. A four second, 10 Hz fiber stimulation was given to release ACh followed by a 
four second, 0.4 nA pulse to induce plateau firing. All experiments were done during 
glutamatergic and gabaergic synaptic blockade using kynurenic acid, a non-selective 
antagonist at NMDA and AMPA/kainate receptors, and picrotoxin a GABAA antago-
nist. As already shown in La neurons, induction of plateau firing in BL neurons was 
possible with a standard carbachol paradigm and by synaptic release of ACh via acti-
vation of SI afferents in the presence of eserine as shown in figure 6.2.7. 
6.2.5 SI afferent stimulation exhibits a biphasic effect in BL neurons 
During testing for plateau firing in BL neurons of the amygdala, it was observed that 
a small cohort of these neurons (8 out of 23) displayed an inhibitory effect following 
stimulation of cholinergic SI afferents. All of these neurons displayed a hyperpolariza-
tion following afferent stimulation and afferent activation was able to fully or partial-
ly inhibit 4 second DC injection which normally induced action potential firing (6 from 
8). Experiments were performed during synaptic blockade by application of kynuren-
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ic acid and picrotoxin as well as ACh augmentation with eserine. As with persistent 
firing studies, afferent stimulation was always given at an intensity that did not pro-
duce action potentials. The stimulus intensity and frequency was varied between 8 
and 14 mV and 10 to 50 Hz respectively. Duration of the stimulus was either 2 or 4 
seconds and the inter stimulus interval was 30 seconds or greater. It was observed 
that SI afferent activation with an ISI that was less than 30 seconds would lead to epi-
leptic like firing and loss of cell. 
Figure 6.2.8 demonstrates a cell which did not exhibit a strong deflection at resting 
VM  following afferent stimulation but did demonstrate inhibition of a 4 second 0.4 
nanoampere DC pulse delivered closely after afferent activation. A 2 second 10 Hz 
stimulation with an ISI of 30 seconds was able to almost fully inhibit the DC pulse; 
stimulation of 40 Hz frequency was able to completely inhibit the direct current in-
jection. A lapse of at least 45 seconds between stimulation negated cholinergic affer-
ent activation. Change in stimulation intensity, duration or membrane potential (less 
negative) did not have an observed effect on DC pulse inhibition. 
Figure 6.2.8 | Cholinergic afferent inhibition in BL neurons Stimulation of cholinergic afferents was able to 
induce inhibition of DC current injection AP fringing in BL neurons. (A) At VM rest, a subthreshold 10 mV 10 Hz 
stimulation of cholinergic afferents was able to partially block a 4 s 0.4 nA suprathreshold current injection. 
Repetition of the stimulation every 30 s was able to elicit greater inhibition but never a full block of the current 
injection. (B) A 10 mV 40 Hz stimulation of cholinergic afferents was able to fully inhibit the suprathreshold DC 
injection. 2 mM kynurenic, 100 µM picrotoxin and 1 µM eserine were all bath applied. Starting VM 70.2 mV 
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Atropine was added to the bath to determine if activation of cholinergic afferents 
was indeed responsible for the observed inhibition in some BL neurons. Figure 6.2.9 
shows the effect of atropine on afferent stimulation and DC injection. A 2 second 10 
Hz pulse with an intensity of 8 mV elicited a hyperpolarization in VM. Upon atropine 
application this hyperpolarization was completely abolished. Increasing the stimula-
tion duration to 4 seconds, the frequency to 50 Hz and the intensity to 14 mV did not 
cause a change in the atropine block of VM deflection by cholinergic afferent activa-
tion. Inhibition of 4 second direct current injection was also abolished in the pres-
ence of atropine. The observed hyperpolarization induced by SI afferent activation 
could be reversed at a more negative VM which was between 20 and 25 mV more 
negative than VM rest. 
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Figure 6.2.9 | Atropine block of cholinergic inhibition (A) A subthreshold stimulation of cholinergic afferents 
at 10 Hz 8 mV induced a hyperpolarization of VM at rest which was reversed at a more negative VM. (B) Bath 
application of 10 µM atropine was able to suppress cholinergic afferent induced membrane deflection at 
stronger stimuli of 14 mV and 10/50 Hz. (C) Inhibition of suprathreshold 0.4 nA 4 s DC injection by a 10 Hz 14 
mV afferent stimulation was also blocked in the presence of 10 µM atropine. 2 mM kynurenic, 100 µM picro-
toxin,   1 µM eserine and 10 µM atropine were all bath applied. Starting VM was at 70.5 mV N: 3 
Hyperpolarization and the inhibition of 4 second DC pulse following cholinergic acti-
vation, by stimulation of SI afferents, did not interfere with the ability of these BL 
neurons to induce plateau firing. Figure 6.2.10 displays a BL neuron which showed 
hyperpolarization as well as inhibition of direct current following SI afferent activa-
Results 
Cline 2010 51 
tion. Acetylcholine release by 10 Hz stimulation at 13 mV was able to completely in-
hibit a 0.2 nA 4 s DC pulse which without prior SI afferent stimulation was able to in-
duce action potentials for the duration of the pulse. Following repeated ACh release 
the 0.2 nA DC pulse showed an increase in firing rate when it did not immediately fol-
low SI activation and came within a time window of less than 45 seconds of the last 
10 Hz stimulus. In order to test the effect of SI afferent stimulation on plateau firing, 
10 Hz 2 second stimulation at 13 mV was given every 30 seconds. This caused a grad-
ual depolarization of membrane potential and eventual plateau firing. Initial plateau 
firing lasted for 65 s before subsiding and VM was allowed to return to rest. SI affer-
ents were then activated as before and again the cell displayed plateau firing which 
lasted until continues DC injection was given to drive the cell to resting membrane 
potential.  
A total of 82 neurons were measured (BL: 66 La: 16) of which 62 showed persistent 
firing (BL: 50 La: 12). 23 of the 50 BL neurons were tested for SI stimulation induced 
plateau firing in the presence of eserine. Interestingly, 8 of these neurons showed a 
hyperpolarizing membrane deflection which was not observed in the La following 
cholinergic afferent stimulation. 6 of the 8 neurons also demonstrated partial or full 
inhibition of a DC pulse which normally elicited AP firing following SI stimulation; 
however, this inhibition did not affect the induction of plateau firing. Results are 
summarized in table 6.2.1 below.   
Table 6.2.1 | Summary of intracellular recordings 
 BL La 
Total Number 66 16 
Membrane potential (VM) 71.2 ± 4.5 70.2 ± 5.2 
afferent stimulation deflection (mV) 9.44 ± 3.38 n/a 
Persistent firing 50 12 
In CCh/eserine 27/23 7/5 
Membrane deflection 8 n/a 
Pulse inhibition 6 n/a 
Biocytin filled 7 3 
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Figure 6.2.10 | Induction of plateau firing from VM rest (A) A 13 mV 10 Hz stimulation of cholinergic afferents 
was able to fully block a 0.2 nA 4 s suprathreshold direct current injection. (B) Afferent stimulation every 30 s 
was able to initiate plateau firing which ceased after 65 s. (C) Further stimulations were able to re-induce plat-
eau firing that lasted until quenched by continuous hyperpolarizing DC injection. (D) The firing frequency of 
suprathreshold 0.2 nA current injection was increased when given between 10 and 20 s following multiple af-
ferent stimulations revealed by peristimulus histogram analysis. 2 mM kynurenic, 100 µM picrotoxin and 1 µM 
eserine were all bath applied. Starting VM 67.8 mV 
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6.3 p75NTR mice 
6.3.1 Genotyping 
p75EXIV animals were genotyped as described in methods. The wild type primer mix-
ture (2590/Mp75Ex4-S3) revealed a band consisting of 345 bp while the ko primer 
mixture (2590/Pgk-2) had a band at 475 bp. Heterozygous animals displayed both 
bands as seen in figure 6.3.1. 
Figure 6.3.1| p75
EXIV
 genotyping (A) gel showing wt animal and ht animal (B) PCR bands corresponding to a ko 
animal and a ht animal. 
6.3.2 Effect of Atropine and Eserine on fEPSPs  
Atropine and eserine significantly potentiated or inhibited the field potential in wt 
animals. Since it is known that p75EXIV animals show a substantial increase in cholin-
ergic innervation bath application of 10 µM atropine and 1 µM eserine was given 
during fEPSP induction using a stimulus which produced a field potential amplitude 
50% of maximum to determine if p75EXIV animals showed differences compared to 
their wild type (wt) counterparts. The maximum effect of atropine on fEPSPs was ob-
served between 15 and 20 minutes from onset which coincides with wt animals. Un-
like wt mice, p75EXIV animals showed no potentiation in the presence of atropine. Ap-
plication of eserine was able to inhibit the field potential in p75EXIV mice but to a less-
er degree as compared to wt mice (Fig. 6.3.2 A, B). The effect of eserine began 
around 5 to 15 minutes following initial application also corresponding to observa-
tions in wt mice, however, unlike wt mice; p75EXIV animals did not show a complete 
inhibition in the field potential after bath application of 30 minutes or more as was 
seen in wt animals as well there was only a negligible increase of fEPSPs threshold in 
p75EXIV animals. In the presence of atropine, p75EXIV animals in fact showed a signifi-
cant depreciation of the field potential (Fig. 6.3.2 A) in contrast with wt mice which 
showed a highly significant potentiation (Fig. 6.2.2 B). Interestingly, atropine applica-
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tion decreased the variability of fEPSPs in p75EXIV animals allowing for this signifi-
cance which otherwise would not have been seen. Unlike in wt animals, atropine did 
not reverse the effect of eserine inhibition back to baseline levels or above in p75EXIV 
mice.  
Figure 6.3.2 | Cholinergic challenge of fEPSPs in p75EXIV mice (A) Challenge of fEPSPs in p75EXIV mice show-
ing significant and highly significant inhibition of the fEPSP for atropine and eserine respectively. (B) compari-
son of cholinergic challenge between wt and p75EXIV animals. Atropine was able to produce a highly signifi-
cant potentiation in wt animals whereas p75EXIV showed a significant inhibition. In both wt and p75EXIV mice 
eserine showed a highly significant inhibition of the fEPSP, however; the degree of inhibition was greater in wt 
animals. 10 µM atropine and 1 µM eserine were bath applied.  
Mann-Whitney test data showed as mean ± sem. 
A atropine eserine B atropine wt atropine ko eserine wt eserine ko 
mean 94.48 70.17 mean 250.6 94.48 47.48 70.17 
sem 1.403 2.161 sem 4.468 1.403 2.114 2.161 
p * *** p *** *** 
N=3   N=3     
As compared to wt animals, p75EXIV animals display an attenuated response to eser-
ine as well as to atropine. The inhibitory effect of the fEPSP in the ko animals is signif-
icantly reduced and the ability of atropine to reverse this inhibition is not present nor 
does atropine cause any potentiation of the fEPSP when applied alone. Wild type and 
ko animals do not show a significant difference in the field potential response during 
application of normal ringer (wt: 2.378 ± 0.2266 ko: 2.578 ± 0.2805, p=ns, N=5). The 
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p75 receptor seems to play a crucial role in cholinergic mediated presynaptic inhibi-
tion; however, a reduced response to cholinergic inhibition in p75EXIV mice does not 
cause an increase in normal field potentials. 
6.3.3 Paired Pulse Facilitation in p75EXIV animals 
Building on the cholinergic challenge of 
fEPSPs, paired pulse facilitation was 
performed in p75EXIV animals. In order 
to determine if there was a difference in 
the ISI for the p2:p1 ratio, preliminary 
test were done as before using a stimu-
lus which produced a field potential 
amplitude of 50% maximum for pulse 
one and an ISI ranging from 10 to 100 
milliseconds. p75EXIV animals showed a 
maximum ratio at 30 ms (Fig. 6.3.3) as 
compared with wt animals which dis-
played the maximum p2:p1 at 40 ms 
(Fig. 6.2.3). To eliminate the possibility of a ceiling effect, p75EXIV animals were tested 
at an ISI of 20 ms. Since eserine was able to increase the PPF ratio at 30 ms, in order 
to maintain congruence with wt animals, PFF test were also performed with an ISI of 
30 ms. During preliminary PPF trials, wt animals showed a relative stable p2:1 be-
tween 50 to 100 ms and an exponential decrease following 100 ms (Fig. 6.2.3), 
p75EXIV animals, however began to decline after 70 ms (Fig. 6.3.3). Eserine increased 
the instability in the PPF ratio after 40 ms whereas atropine induced stability (Fig. 
6.3.4). Two-way ANOVA with Bonferroni posttest however revealed that the eserine 
instability was insignificant, whereas atropine had a significant affect by preserving 
the increased p2:p1 ratio for ISIs 50 to 100 ms. This is in contrast to wt animals 
where atropine returned the PPF ratio back to baseline levels. At 20 and 30 ms inter-
stimulus intervals, p75EXIV mice, to a lesser extent, resembled their wt counterparts. 
Figure 6.3.1 | PPF ISI paired pulse facilitation with 
varying inter stimulus intervals from 10 to 100 ms. at 
50% maximum amplitude. N: 5 
ISI (ms) mean sem ISI (ms) mean sem 
10 1.025 0.03211 60 1.128 0.03832 
20 1.167 0.04039 70 1.073 0.02864 
30 1.295 0.06380 80 0.9957 0.08622 
40 1.264 0.03393 90 0.8771 0.04509 
50 1.138 0.02555 100 0.9155 0.009926 
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Figure 6.3.4 | Paired pulsed facilitation p75EXIV ISIs PPF in p75
EXIV
 mice at ISIs between 10 and 100 ms. (A) 
application of eserine insignificantly disrupted the p2:p1 ratio (B) atropine did not fully restore p2:p1 to base-
line levels but did significantly maintain a stable level similar to ISI 40 in baseline conditions for ISIs 40 to 100 
ms. Data are presented as mean ± sem summary of Two-way ANOVA with Bonferroni posttests are in table 
below 
 ringer eserine atropine ringer vs eser ringer vs atro eser vs atro 
10 1.025±0.026 1.172±0.050 1.056±0.024 ns ns ns 
20 1.167±0.036 1.391±0.036 1.203±0.029 *** ns ** 
30 1.295±0.053 1.445±0.051 1.331±0.040 ns ns ns 
40 1.264±0.032 1.343±0.028 1.239±0.018 ns ns ns 
50 1.138±0.021 1.020±0.029 1.257±0.026 ns ns *** 
60 1.128±0.047 1.179±0.046 1.226±0.028 ns ns ns 
70 1.073±0.042 0.913±0.026 1.247±0.030 * * *** 
80 0.988±0.060 1.040±0.068 1.272±0.030 ns *** *** 
90 0.877±0.048 1.014±0.053 1.241±0.027 ns *** *** 
100 0.915±0.020 1.042±0.043 1.215±0.023 ns *** * 
N=5       
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As previously stated PPF experiments in wt and ko animals were conducted using an 
ISI of 30 and 20 ms respectively to avoid a celling effect. To compare ko and wt ani-
mals, an ISI of 30 ms was also utilized in the ko animals. Two-way ANOVA analysis 
with Bonferroni posttest did not reveal any differences between p75EXIV and wt ani-
mals at either 20 or 30 ms ISIs (Fig. 6.3.5). Both groups displayed significant differ-
ences in the PPF ratio between eserine and atropine except at ISI 30 ms for ko ani-
mals. The overall effect of eserine or atropine on the PPF ratio was not as strong in 
p75EXIV mice as in wt coinciding with field potential results. Wild type animals showed 
an overall general increased PPF ratio and reach a maximum PPF at a longer ISI than 
ko mice indicating that the loss of the p75 receptor interferes with normal transmit-
ter release. A summary of the results are found in the corresponding table below Fig. 
6.3.5.   
Figure 6.3.5 | Paired Pulse Facilitation p75EXIV mice vs wt PPF was carried out at 20 ms to eliminate the 
chance of a ceiling effect and at 30 ms to compare with wt animals. Data: Two-way ANOVA with Bonferroni 
posttests, plotted as mean ± sem.   
 wt eserine wt atropine ko eserine ko atropine 
20 1.500±0.036 1.183±0.029 1.391±0.036 1.203±0.029 
30 1.554±0.051 1.320±0.040 1.445±0.051 1.331±0.040 
20 vs wt atro *** vs ko atro ns vs ko atro **  
30 vs wt atro *** vs ko atro ns vs ko atro ns  
20 vs ko eser ns    
30 vs ko eser ns    
N=5     
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6.4 LTP 
6.4.1 LTP induction in wt animals 
LTP indcution in wt animals was performed using a standard high frequency stimulus 
paradigm consisting of a stimulus that induced 50% amplitude of the maximum for 
field potentials and induced via external capuslue stimulation (Fig. 6.2.1). Wild type 
animals showed a stable, higly significant LTP (159.9 ± 0.6127 ***p < 0.001; N=5) that 
could be meausered for at least 60 minutes or longer (Fig. 6.4.1 A). Baseline and LTP 
was stable through out recordings and induction of LTP occurred in approximately 
60% of induction attempts. As no differences were observed between the La and BL, 
data was combined (Fig. 11.1.1, appendix). 
6.4.2 LTP induction in p75EXIV animals 
Induction in ko animals occurred in only about 35% of attempts and did not last for 
longer than 35 ± 10 minutes (Fig. 6.4.1 B). The standard paradigm as used in wt mice 
had to be modified in that the induction baseline of 50% maximum amplitude did not 
induce LTP and therefore, the baseline induction amplitude was between 50 and 60% 
of the maximum field potential induced with EC stimulation. Baseline as well as LTP 
showed greater variability and it was often the case that a stable baseline of 20 
minutes could not be obtained. However p75EXIV did show a significant potentiation 
compared to baseline on the same level as wt animals (161.4 ± 1.100 ***p < 0.001; 
N=5) Input/output curves did not reveal any differences between p75EXIV and wt mice 
(Fig. 6.4.2). In all attempts, it was never possible to achieve a stable LTP in p75EXIV an-
imals for 60 min or longer as in wt mice, indicating that the p75 neurotrophin recep-
tor may play an important function in LTP maintenance.  
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Figure 6.4.1 | LTP LTP in wt and p75EXIV mice induced by HFS stimulation (A,B) Time course for LTP in wt and 
ko (C,D) Mann-Whitney analysis of last 10 min for wt and min 20 to30 for ko reveals highly significant LTP po-
tentiation in both wt and ko mice (E,F) Kruskal-Wallis analysis with Dunns Multiple Comparison Test shows no 
significant difference between wt and ko mice at 20-30 min (E) and highly significant differences for 50 to 60 
min (F). It must be noted that for B time 30-60 min and for F the N for ko animals is only 2. 
(C,D) wt: 159.9 ± 0.6127 | ko: 161.4 ± 1.100 ***p < 0.001 n: 5 (E) wt: 159.9 ± 0.6127 | ko: 161.4 ± 1.100 ns n: 5 
(F) wt: 159.9 ± 0.7012 ko: 78.22 ± 4.193 wt n: 5 ko n: 2 
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Figure 6.4.2 | I/O curves I/O curves for p75EXIV mice and wt mice Two-way ANOVA with Bonferroni posttests 
reveals no differences between wt and p75EXIV mice N: 5 
6.4.3 Cholinergic challenge of LTP 
Bath application of either 1 µM eserine or 10 µM atropine before HFS induction was 
used to determine a cholinergic effect on LTP in wt animals. As expected based upon 
fEPSPs, eserine prohibited LTP induction. Since eserine application caused an in-
crease in threshold, a higher intensity HFS stimulus (80% of maximum amplitude) 
was also given resulting in either no LTP or short lived LTP lasting 2 to 5 minutes and 
in rare occasions, induction of LTD. As all observations were not readily reproducible 
with higher intensity HFS data are not shown. Also in congruence with fEPSPs, atro-
pine blocked LTP formation as it already created potentiation greater than that nor-
mally reached by standard HFS induction. Due to lack of animals, experiments were 
not repeated in p75EXIV mice.  
Figure 6.4.3 | Cholinergic challenge of LTP Challenge of LTP by either esering or atropine show no effect. 
Mann-Whitney N: 5 
 
 wt ko p 
3 1.409 ± 0.179 1.316 ± 0.260 ns 
4 2.063 ± 0.192 2.293 ± 0.293 ns 
5 2.460 ± 0.189 2.757 ± 0.254 ns 
6 2.715 ± 0.208 3.048 ± 0.211 ns 
7 2.882 ± 0.227 3.149 ± 0.211 ns 
8 2.736 ± 0.073 2.904 ± 0.528 ns 
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7 Discussion 
7.1 Immunohistochemistry  
7.1.1 ChAT Staining 
As was expected, in control animals, ChAT immunohistochemistry showed a signifi-
cant difference between the amygdala nuclei BL and La. This corresponds with what 
has been previously reported in the literature and provides a basis for the relative 
few differences observed between the two nuclei during electrophysiological record-
ings. ChAT staining also provided strong support that the horizontal slice preparation 
was a suitable means for subsequent electrophysiological studies in that the BL and 
La nuclei were readily accessible and identifiable, cholinergic SI afferents could easily 
be stimulated and both nuclei received SI innervation on this plane, the fiber tract of 
the EC was also intact providing a stimulation site for cortical afferent input for both 
the BL and La nuclei. What could also be seen in the horizontal slice preparation, but 
was not investigated, was the clear difference in cholinergic innervation of the 
amygdala as compared to other brain areas as previously reported [187].  
Cholinergic projections to the amygdala from the SI appear to be the only known 
cholinergic pathway in the basal forebrain that do not necessarily express the p75 
neurotrophin receptor as elucidated with IgG-saporin injections; suggesting at least 
two types of cholinergic projections to the amygdala [67, 68]. Although the BL 
showed significantly higher intensity for ChAT as compared to the La when measured 
with ImageJ, the subsequent electrophysiology deployed here failed to elucidate a 
strong cholinergic difference between the two nuclei except for intrinsic studies. This 
also corresponds with what has already been reported where differences are readily 
seen in patch studies but not field studies despite the known difference in cholinergic 
innervation of the BL and La nuclei and resulting in reference given only to the full 
BLA and no distinction being made between the individual BL and La nuclei. 
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7.1.2 Cholinergic challenge of fEPSPs 
Bath application of 1 µM eserine or 10 µM atropine was able to inhibit/block and po-
tentiate the field potential in both the BL and La of wt animals respectively. In p75EXIV 
animals, the effect of eserine or atropine on the fp was attenuated. Atropine in 
p75EXIV actually resulted in a slight depreciation in sharp contrast to the high potenti-
ation in the wt animals. The attenuation of the inhibitory effect of eserine in ko ani-
mals can be attributed to a lower release of ACh as p75 depleted cells do show a 3.7 
fold decrease in ACh levels [188]; however, the lower release did not affect the fp for 
p75EXIV animals in normal ringer. A possible explanation for this is discussed in the 
next section as it relates to differences seen in paired pulse facilitation.   
Activation of mAChRs inhibits presynaptic transmitter release through activation of 
gabaergic interneurons and this is the most obvious explanation for the seen de-
crease in fESPs for wt mice. As well, in the case of atropine potentiation in wt ani-
mals, it can also be argued that the effect is due to blockade of mAChRs by atropine 
allowing an increase of the fp by greater transmitter release [33, 69, 189]. The ob-
served inhibitory effect of acetylcholine agonist is in agreement in studies elsewhere. 
Yajeya et al. [190] showed that carbachol dose dependently suppressed the excitato-
ry postsynaptic potential in BL and La neurons using a sharp microelectrode protocol 
and stimulation of the external capsule to elicit orthodromic EPSPs. This carbachol 
induced suppression of the EPSP was completely blocked by application of atropine 
which is in agreement with the field studies presented here. The ability of atropine to 
potentiate the fESP as shown here is implied in the study by Yajeya et al. but he 
makes note of the necessity for further investigation on the intrinsic effect of atro-
pine on the ESP as his report did not look at atropine applied alone. As it is known 
that the cholinergic system plays a vital role in information processing for the amyg-
dala, these data here suggest possible learning/memory impairment for p75EXIV mice 
as they have a significant change in their response to cholinergic challenge. 
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7.1.3 Cholinergic challenge of paired pulse facilitation  
The p2:p1 ratio reached a peak in wt animals at an ISI of 40 milliseconds while p75EXIV 
mice showed a peak at 30 ms indicating a difference in transmitter release probabil-
ity for the two groups as such; wt animals show a greater release probability as com-
pared to ko animals. This coincides with fEPSPs results in that the wt mice demon-
strate stronger fp inhibition during eserine application as compared to ko animals as 
a result of stronger mAChR activation. It also provides a possibly explanation for the 
differences between p75EXIV mice and wt mice with regard to atropine application. 
Since wt animals have greater transmitter release probability, it can be suggested 
that 1: the basal level of ACh in p75EXIV animals is lower (due to release probability) 
giving rise to a larger fp in baseline, (due to diminished presynaptic inhibition via 
mAChRs) which was not significant to wt animals, resulting in a lower effect of atro-
pine and 2: since the stimulation site of the EC is not exclusively cholinergic, it can 
also be suggested that release probability as a whole for p75EXIV is diminished so that 
in the presence of atropine and muscarinic block, glutamate release is also lower 
than that of wt animals resulting in no potentiating effect for ko animals as in wt. It 
has been shown that lesioning of neurons which express p75NTR results in reduced 
basal levels of acetylcholine as well as release [191].  
The data here evidence that both ACh levels and release probability are most likely 
working together. I/O curves for p75EXIV display a more exponential curve and reach 
plateau faster than that of wt animals indicating stronger field potentials; however, 
there were no significant differences in I/0 curves between ko and wt animals. The 
p2:p1 ratio is increased significantly more in wt animals as ko mice in the presence of 
eserine indicating greater presynaptic inhibition for the wt mice and indirectly a 
greater release probability of ACh. Application of atropine returns the PPF ratio back 
to baseline levels for wt mice at all ISIs whereas in p75EXIV animals, atropine does not 
fully return the ratio to baseline levels. This is especially true for ISIs greater than 40 
ms where the ratio stays elevated which could also indirectly hint at a stronger fp for 
p75EXIV mice due to a lack of presynaptic inhibition via mAChR activation which was 
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not seen during fp induction in normal ringer. Finally, it must also be noted that NGF 
and ACh have a synergetic relationship in that NGF release augments the release of 
ACh as well as the reuptake of choline for greater ACh production. Likewise, ACh re-
lease enhances the release of NGF creating a positive feedback loop [192]. Most im-
portantly, it has recently been reported that the enhanced release of ACh by NGF is 
dependent upon the p75 neurotrophin receptor [193]; providing the best explana-
tion for the observed cholinergic differences seen here which indicate lower ACh re-
lease/levels in p75EXIV animals. Coinciding with data from cholinergic challenge of the 
field potential, the discrepancy in PPF between wt and p75EXIV animals also gives cre-
dence to a disruption in the normal cholinergic response for these animals as well as 
a high probability for problems associated with learning and memory. The PPF data 
here are in agreement with reports that carbachol increased the paired pulse ratio in 
the entorhinal cortex via presynaptic inhibition [194] which was blocked by atropine. 
A CCh induced increase of the PPF ratio was also observed in the hippocampus [195].  
7.1.4 Plateau firing 
It was possible to initiate plateau firing in neurons of the basolateral and lateral 
amygdala nuclei by two standard methods that have been previously reported [9, 
124]. During bath application of carbachol, in both nuclei plateau firing was induced 
by holding VM to just below threshold (10 to 12 mV more negative) with direct cur-
rent injection and eliciting plateau firing with a 0.2 to 0.4 nA 4 second suprathreshold 
pulse. As well, persistent activity could also be induced in both nuclei in the presence 
of eserine, using the same VM hold technique and stimulating cholinergic substantia 
innominata afferents directly before the suprathreshold pulse. However, unlike what 
has been reported for La neurons [9] as well as the data presented here, it was also 
possible to induce plateau firing in BL neurons by continuously stimulating SI affer-
ents every 30 seconds from VM rest.  
A possible explanation for the differences in plateau induction between the BL and 
La is the greater cholinergic innervation of the BL. This would provide for greater ace-
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tylcholine release resulting in a possible larger rise in postsynaptic calcium levels by 
mAChR activation of the IP3 cascade. This in turn, leads to a gradual depolarization 
and eventual action potential firing and is in line with a non NMDAR form of LTP 
which has been coined LTPIP3 [110] 
Another phenomenon that was present in BL neurons but absent in La was the ability 
of SI afferent stimulation to cause a hyperpolarizing membrane deflection. When a 
suprathreshold DC pulse was given immediately following this deflection it was 
blocked. Neurons that displayed this VM hyperpolarized deflection were still able to 
produce plateau firing following repeated 30 second ISI SI afferent stimulation. Again 
greater cholinergic innervation of the BL could account for this observed difference. 
Muscarinic acetylcholine receptors also activate SK channels causing a brief hyperpo-
larization of membrane potential, yet this only occurs when ACh acts on soma and 
proximal dendrites [70]. Greater cholinergic innervation of the BL would provide 
greater probability that ACh could act at somatic and proximal dendritic sites as well 
as distal dendritic sites, where in the La, most ACh activity would only occur distally. 
The data here also show that the ability of SI stimulation to inhibit a suprathreshold 
pulse was dependent upon stimulation frequency and not duration or intensity 
providing evidence this inhibition could be related to the frequency of SK channel ac-
tivation. Stronger SI stimulation intensities resulted in greater membrane depolariza-
tion and a higher probability of AP firing most likely due to greater ACh release and 
stronger induction of the IP3 pathway. It has been shown that IP3 pathway blockade 
prevents plateau firing in La neurons [9] and SK channel block increases mAChR in-
duced membrane depolarization as well as AP firing [70].  
In line with this study but using a LTP paradigm, Park et al. [196] showed that car-
bachol was able to induce a transient depression of the field potential in the lateral 
amygdala yet also induce a form of LTP both the depression and LTP were observed 
in the presence of picrotoxin. The initial transient depression did not interfere with 
the ability of CCh to induce a postsynaptic form of LTP which was dependent upon 
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the cAMP pathway. Both the initial transient depression as well as the induced L-LTP 
could be blocked by atropine. Inhibition of the cAMP pathway blocked LTP induction 
by carbachol but not the initial transient inhibition. This is in agreement with the da-
ta presented here that the membrane deflection seen following SI stimulation in BL 
neurons did not interfere with the ability of these neurons to induce plateau firing 
initiated by repeated SI stimulation every 30 seconds suggesting that the initial de-
flection is presynaptic and, coinciding with previous reports, the plateau potential is 
a postsynaptic event relying on second messenger cascades [9].   
The cholinergic system appears to be able to modulate both network activity and in-
trinsic activity in the amygdala. Presynaptic inhibition controls network excitability 
while activation of SK channels can regulate the excitability of single neurons regard-
less of network activity. Still, even when individual neurons or the network are re-
ceiving substantial inhibition, acetylcholine can act postsynaptically via second mes-
senger pathways to induce plateau firing in individual neurons or LTP in the network.     
7.2 LTP 
7.2.1 p75EXIV vs wt animals 
Wt and p75EXIV animals did not differ in LTP potentiation as compared to baseline; 
however, LTP of 60 minutes or greater was not possible to achieve in ko animals with 
the standard HFS induction paradigm deployed here. The loss of the p75 neurotro-
phin receptor could disrupt postsynaptic calcium release and thereby hindering LTP 
maintenance which is virtually always a postsynaptic event. Still, with other induction 
paradigms such as TBS, or other experimental conditions such as GABAergic synaptic 
blockade, LTP duration of 60 minutes or greater might be achieved in these animals. 
HFS was selected here since it is generally considered to be a more robust induction 
paradigm and it has been shown that TBS fails to elicit LTP in the amygdala via EC fi-
ber stimulation [197]. As it is generally agreed that L-LTP is dependent upon protein 
synthesis, it may also be that the lack of the p75 neurotrophin receptor disrupts pro-
tein synthesis in p75EXIV mice and therefore L-LTP. It has been shown in hippocampal 
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LTP that the lack of BDNF interacting with TrkB disrupts HFS induced LTP and pre-
vents the formation of L-LTP [198]. Cleary the lack of the p75 receptor disrupts HFS 
LTP in p75EXIV animals as a higher intensity stimulus must be deployed of 50 to 60% 
maximum amplitude and L-LTP is lacking in these mice. So a synergy between NGF, 
p75NTR and TrkA could be necessary for L-LTP protein synthesis as well.    
In the data here, p75EXIV animals have a clear disruption in LTP in that LTP was never 
induced for a period longer than 30 minutes and required a stronger induction as 
that for wt animals. However, LTP was not fully abolished in these animals suggesting 
that p75EXIV animals may show learning deficits based upon the type of learning as 
not all task would be dependent on L-LTP. This corresponds well with the field poten-
tial and PPF studies in that the p75EXIV animals are showing a clear impairment in 
normal ACh response but not a complete lack thereof.  
There is currently little reported about these animals in the literature and what is 
available is conflicting. Catts et al. [199] showed that p75NTR -/- animals demon-
strated impairment in the Morris water maze along with decreased neurogenesis and 
higher cell death of new cells. They suggested that the findings are most likely a re-
sult of altered circuitry due to the loss of p75NTR. Barrett et al. [200] showed con-
flicting results in that they reported p75NTR -/- animals demonstrated enhanced spa-
tial memory as revealed by the Morris water maze and enhanced hippocampal LTP. 
The differences in the studies could be related to the background strain of the ani-
mals used. Barrett reports using a 129/Sv strain and the animals are p75EXIII mice 
which still possess a truncated p75NTR allele while Catts animals were backcrossed 
into a C57/BL6 strain and procured from Jackson Laboratories indicating the mice 
were also p75EXIII. While the report from Barrett also contradicts the LTP data here, it 
must also be noted the strain difference, that the animals here were p75EXIV which do 
not possess the truncated allele and experimental design. Despite the early conflict-
ing reports it is clear that animals lacking the p75NTR have disruptions in learning 
and memory.        
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7.2.2 Cholinergic challenge of LTP 
Eserine applied before induction was able to block LTP induction by increased pre-
synaptic inhibition whereas atropine application preceding induction showed no ef-
fect. Following LTP induction, application of either eserine or atropine did not disrupt 
LTP indicating that LTP maintenance is most likely postsynaptic and it has been 
shown that LFS stimulation following LTP induction via the EC fiber pathway also did 
not affect LTP [197]. Of interesting note, LFS induction of LTP was also possible in the 
amygdala only via stimulation of EC fibers which resulted in a slow onset, greater 
than 60 minutes and dependent upon protein synthesis further indicating postsynap-
tic maintenance [201]. Unfortunately due to a lack of p75EXIV animals, cholinergic 
challenge of LTP was not performed. It has been shown that in the hippocampus at-
ropine will either enhance or suppress LTP induction depending on the induction site 
although the reported enhancement was not significant [202, 203]. 
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8 Conclusion 
8.1 Plateau firing 
Intrinsic plateau firing differed between the BL and La amygdala nuclei as greater 
cholinergic innervation of the BL allows stronger ACh release at somatic and proximal 
dendritic sites which gives rise to a robust biphasic effect of ACh which is not ob-
served in La neurons where ACh primarily only acts at distal dendritic sites. Distal 
dendritic activation causes an inhibition of the after hyperpolarization current allow-
ing excitation, whereas proximal and somatic activation creates a competition be-
tween small conductance, calcium activated, potassium channels, which cause hy-
perpolarization, and the inhibition of the AHP. BL neurons in the presence of eserine 
displayed this biphasic effect of ACh seen as a hyperpolarization membrane deflec-
tion following cholinergic SI afferent stimulation. As well, repeated cholinergic affer-
ent stimulation every 30 s was able to induce plateau firing in BL neurons during es-
erine application but not in La neurons. As with the initial hypothesis, the higher cho-
linergic innervation of the BL, compared to that of the La, causes a difference in in-
trinsic firing properties of projection neurons of both nuclei.       
8.2 Cholinergic Challenge  
Unlike sharp recordings, extracellular field recordings did not elucidate a difference 
between the BL or La nuclei. Application of eserine or carbachol always caused a 
time dependent reduction of the field potential which could be blocked and reversed 
by atropine. Eserine also increased the threshold properties for the field potential. 
When atropine was bath perfused alone, it induced a substantial potentiation of the 
fp.    
Contradictory to the initial hypothesis, p75EXIV did not demonstrate a greater re-
sponse to cholinergic challenge as was expected due to the increased cholinergic fi-
ber density for these animals. These mice showed an attenuation of the presynaptic 
inhibitory effect of eserine as well as no potentiation to atropine alone in fEPSPs ex-
Conclusion 
Cline 2010 70 
periments. Paired pulse facilitation revealed that the ko animals have a lower release 
probability as well as reduced presynaptic inhibition as evidence by a smaller PPF ra-
tio as compared with their wt counterparts.   
8.3 LTP 
It was also predicted that the p75EXIV mice would show enhanced LTP when initiated 
in a way that the cholinergic system would be activated. Compared to wt animals, 
p75EXIV showed a disruption in LTP induction as the HFS paradigm had to be carried 
out at higher stimulus intensity in these animals. They also only showed LTP in essen-
tially 34% of induction attempts as compared to 60% for wild types. The level of LTP 
reached was comparable to wt when correlated at 20 to 30 minutes; however, p75 
mice never showed LTP for 60 minutes or more. In fact, only 2 out of 5 animals test-
ed, demonstrated LTP for greater than 30 minutes and these two quickly fell below 
baseline levels.        
Agreeing with fEPSPs studies, there were no differences seen between the BL or La 
nuclei. Unlike fEPSPs experiments, cholinergic challenge did not affect LTP induction 
or maintenance in wt animals. It was not seen if this was the case in p75EXIV animals 
due to insufficient mice. 
8.4 Summary 
Projection neurons of the BL and La show intrinsic firing differences due to higher 
cholinergic innervation of the BL. 
The differing cholinergic innervation of the BL and La does not affect fEPSPs or LTP. 
p75EXIV mice have lower release probability resulting in an attenuated cholinergic re-
sponse. 
p75EXIV mice show a disruption in LTP induction as well as a lack of L-LTP in a HFS LTP 
induction paradigm. 
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9 Out Look 
It would be necessary to further study LTP in the p75EXIV animals as the numbers here 
are insufficient to draw proper conclusions. However, the evidence of a lack of L-LTP 
is quite interesting and this should be followed up along with at least western blot 
analysis. 
Intracellular recordings in the p75EXIV animals would also need to be done as well 
with blockade of SK channels to fully understand intrinsic differences underlying cho-
linergic responses between wt and ko animals. 
Finally, behavior experiments that coincide with the amygdala LTP paradigms pre-
sented here such as fear conditioning or learned helplessness would be of great in-
terest.  
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Figure 8.4.1 | BL vs La control Control studies to test differences between the BL and La nuclei of the amygda-
la. (A) Field potential recordings revealed no differences between the BL and La for normal ringer (not shown) 
or challenge with either 10 µM atropine or 1 µM eserine. (B) No difference in LTP magnitude was seen be-
tween the BL or La. (C,D) Paired Pulse Facilitation did not elucidate a difference between the BL or La in normal 
ringer (not shown) or with cholinergic challenge (10 µM atropine, 1 µM eserine) Drugs were bath applied. All 
data were analyzed using Mann-Whitney and presented as mean ± sem. (A,C,D) Were graphed together for 
simplicity. 
 A B C D 
 eserine atropine n/a eserine atropine eserine atropine 
BL 41.35 ± 2.677 
255.0 ± 
6.857 
159.6 ± 4.185 
1.554 ± 
0.051 
1.32 ± 0.04 
1.391 ± 
0.036 
1.203 ± 
0.029 
La 48.4 ± 2.96 
247.0 ± 
10.05 
160.2 ± 3.407 
1.514 ± 
0.060 
1.375 ± 
0.041 
1.401 ± 
0.039 
1.234 ± 
0.022 
p ns ns ns ns ns ns ns 
n 5 5 3 5 
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Figure 8.4.2 | Stimulator and Electrode Placements (A) Diagram depicting the plane of the horizontal slice 
preparation used for field recordings, PPF, and LTP and the approximate placements of stimulator and microe-
lectrodes. (B) Placements of stimulator and microelectrodes for simultaneous recording in BL and La during  fp, 
PPF, and LTP paradigms. (C) Placements during intracellular recording in either La or BL. Modified from Paxinos 
1998 [186] 
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